Carlyle Group (NASDAQ: CG) lifts AUM to $477B and expands credit, AlpInvest
The Carlyle Group Inc. reports strong 2025 growth with assets under management rising to $477 billion, up 8% from $441 billion. The firm generated $53.7 billion of inflows, a 32% increase, and deployed $54.5 billion while realizing $34.1 billion of proceeds for carry fund investors.
Global Credit was the largest segment with $211.3 billion of AUM, up 10%, while Carlyle AlpInvest reached $102.0 billion, a 20% gain, and Global Private Equity managed about $163.5 billion. Carlyle returned approximately $0.9 billion to shareholders through $505 million of dividends and $400 million of share repurchases.
The carry fund portfolio appreciated 8% in 2025, supported by realizations in private equity, active credit issuance including nine new CLOs, and strong secondary and co‑investment activity. The board reset the share repurchase authorization to $2.0 billion and Carlyle issued $800.0 million of 5.050% senior notes due 2035, adding long-term financing flexibility.
Positive
- None.
Negative
- None.
Insights
2025 shows solid AUM and activity growth, but within a steady expansion path.
Carlyle expanded AUM to
The carry fund portfolio appreciated
Carlyle returned roughly
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
☒ | Accelerated filer | ☐ | ||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||
Emerging growth company |
Page | ||
PART I. | ||
ITEM 1. | BUSINESS | 7 |
ITEM 1A. | RISK FACTORS | 28 |
ITEM 1B. | UNRESOLVED STAFF COMMENTS | 86 |
ITEM 1C. | CYBERSECURITY | 87 |
ITEM 2. | PROPERTIES | 88 |
ITEM 3. | LEGAL PROCEEDINGS | 88 |
ITEM 4. | MINE SAFETY DISCLOSURES | 88 |
PART II. | ||
ITEM 5. | MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES | 89 |
ITEM 6. | [RESERVED] | 91 |
ITEM 7. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 92 |
ITEM 7A. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 145 |
ITEM 8. | FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA | 148 |
ITEM 9. | CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE | 219 |
ITEM 9A. | CONTROLS AND PROCEDURES | 219 |
ITEM 9B. | OTHER INFORMATION | 220 |
ITEM 9C. | DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS | 220 |
PART III. | ||
ITEM 10. | DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE | 221 |
ITEM 11. | EXECUTIVE COMPENSATION | 221 |
ITEM 12. | SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS | 221 |
ITEM 13. | CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE | 221 |
ITEM 14. | PRINCIPAL ACCOUNTANT FEES AND SERVICES | 221 |
PART IV. | ||
ITEM 15. | EXHIBITS AND FINANCIAL STATEMENT SCHEDULES | 222 |
ITEM 16. | FORM 10-K SUMMARY | 226 |
AUM(1) | % of Total AUM | Fee-earning AUM | Active Investments | Active Funds(1) | Available Capital | Investment Professionals(2) | Amount Invested Since Inception | Investments Since Inception | ||||||||
$164 | 34% | $101 | 975+ | 75 | $39 | 430 | $245 | 2,700+ |
AUM | % of Total AUM | Fee-earning AUM | Available Capital | Active Funds | Investment Professionals | |||||
$211 | 44% | $169 | $19 | 142 | 205+ |
AUM | % of Total AUM | Fee-earning AUM | Fund Vehicles | Available Capital | Investment Professionals | Amount Invested Since Inception | ||||||
$102 | 21% | $66 | 461 | $30 | 125+ | $111 |
Global Private Equity | $163.6 | Global Credit | $211.3 | |
Corporate Private Equity | $104.3 | Insurance Solutions 4 | $86.9 | |
U.S. Buyout (CP) | 52.8 | Liquid Credit | $50.1 | |
Asia Buyout (CAP) | 11.5 | U.S. CLOs | 35.4 | |
Europe Buyout (CEP) | 9.8 | Europe CLOs | 10.1 | |
Carlyle Global Partners (CGP) | 6.8 | CLO Investment Products | 2.5 | |
Japan Buyout (CJP) | 6.0 | Revolving Credit | 2.0 | |
Europe Technology (CETP) | 5.5 | Private Credit | $74.4 | |
U.S. Growth (CP Growth / CEOF) | 3.2 | Opportunistic Credit (CCOF / CSP) | 20.3 | |
Life Sciences (ABV / ACCD) | 2.2 | Direct Lending 5 | 13.6 | |
Asia Growth (CAP Growth / CAGP) | 1.1 | Aviation Finance (SASOF / CALF) | 12.8 | |
Other 1 | 5.4 | Asset-Backed Finance | 10.2 | |
Real Estate | $36.0 | Cross-Platform Credit (incl CTAC) | 10.0 | |
U.S. Real Estate (CRP) | 25.0 | Infrastructure (CICF) | 6.9 | |
Core Plus Real Estate (CPI) | 8.4 | Other 6 | 0.5 | |
International Real Estate (CER) | 2.5 | |||
Infrastructure & Natural Resources | $23.3 | Carlyle AlpInvest | $102.0 | |
NGP Energy 2 | 10.8 | Secondaries & Portfolio Finance (ASF / ASPF) | $45.7 | |
Infrastructure and Renewable Energy 3 | 7.1 | Co-Investments (ACF) | $24.1 | |
International Energy (CIEP) | 5.4 | Primary Investments & Other 7 | $32.2 | |

Period | (a) Total number of shares purchased | (b) Average price paid per share | (c) Total number of shares purchased as part of publicly announced plans or programs | (d) Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs (3) |
(Dollars in millions, except unit and per unit data) | ||||
October 1, 2025 to October 31, 2025 (1) | — | $— | — | $779.3 |
November 1, 2025 to November 30, 2025 (1)(2) | 2,574,274 | $52.55 | 2,574,274 | $644.0 |
December 1, 2025 to December 31, 2025 (1)(2) | 713,330 | $55.69 | 713,330 | $604.3 |
Total | 3,287,604 | 3,287,604 | ||
2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||||||||
Date of Agreement: | ||||||||||||||
February 1, 2020 | 89,820 | — | — | — | — | — | — | |||||||
February 1, 2021 | 87,419 | 87,418 | — | — | — | — | — | |||||||
February 1, 2022 | 75,290 | 56,467 | 56,467 | — | — | — | — | |||||||
February 1, 2023 | — | 103,432 | 77,574 | 77,573 | — | — | — | |||||||
February 1, 2024 | — | — | 98,918 | 74,188 | 74,187 | — | — | |||||||
February 1, 2025 | — | — | — | 68,757 | 51,567 | 51,567 | — | |||||||
February 1, 2026 | — | — | — | — | 50,603 | 37,952 | 37,952 | |||||||

As of December 31, | |||
2025 | 2024 | ||
Consolidated Results | (Dollars in millions) | ||
Components of Fee-earning AUM | |||
Fee-earning AUM based on capital commitments | $71,611 | $58,885 | |
Fee-earning AUM based on invested capital | 80,814 | 81,826 | |
Fee-earning AUM based on collateral balances, at par | 44,455 | 45,890 | |
Fee-earning AUM based on net asset value | 30,151 | 23,369 | |
Fee-earning AUM based on fair value and other | 109,747 | 94,388 | |
Balance, End of Period(1) | $336,778 | $304,358 | |
Year Ended December 31, | |||
2025 | 2024 | ||
Consolidated Results | (Dollars in millions) | ||
Fee-earning AUM Rollforward | |||
Balance, Beginning of Period | $304,358 | $307,418 | |
Inflows(1) | 55,584 | 32,971 | |
Outflows (including realizations)(2) | (29,787) | (31,289) | |
Market Activity & Other(3) | 1,845 | (1,856) | |
Foreign Exchange(4) | 4,778 | (2,886) | |
Balance, End of Period | $336,778 | $304,358 | |

Year Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Consolidated Results | |||
Total AUM Rollforward | |||
Balance, Beginning of Period | $441,020 | $425,994 | |
Inflows(1) | 53,692 | 40,781 | |
Outflows (including realizations)(2) | (43,280) | (36,575) | |
Market Activity & Other(3) | 18,046 | 15,220 | |
Foreign Exchange(4) | 7,389 | (4,400) | |
Balance, End of Period | $476,867 | $441,020 | |
Year Ended December 31, | Change | ||||||
2025 | 2024 | $ | % | ||||
(Dollars in millions) | |||||||
Revenues | |||||||
Fund management fees | $2,396.6 | $2,188.1 | $208.5 | 10% | |||
Incentive fees | 190.5 | 133.5 | 57.0 | 43% | |||
Investment income | |||||||
Performance allocations | 1,222.5 | 2,015.7 | (793.2) | (39)% | |||
Principal investment income | 119.2 | 238.7 | (119.5) | (50)% | |||
Total investment income | 1,341.7 | 2,254.4 | (912.7) | (40)% | |||
Interest and other income | 215.7 | 218.2 | (2.5) | (1)% | |||
Interest and other income of Consolidated Funds | 635.3 | 631.6 | 3.7 | 1% | |||
Total revenues | 4,779.8 | 5,425.8 | (646.0) | (12)% | |||
Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | 895.2 | 875.5 | 19.7 | 2% | |||
Equity-based compensation | 374.7 | 467.9 | (93.2) | (20)% | |||
Performance allocations and incentive fee related compensation | 936.3 | 1,361.5 | (425.2) | (31)% | |||
Total compensation and benefits | 2,206.2 | 2,704.9 | (498.7) | (18)% | |||
General, administrative and other expenses | 784.3 | 665.6 | 118.7 | 18% | |||
Interest | 123.9 | 121.0 | 2.9 | 2% | |||
Interest and other expenses of Consolidated Funds | 624.3 | 564.9 | 59.4 | 11% | |||
Other non-operating expenses (income) | (0.2) | (0.3) | 0.1 | (33)% | |||
Total expenses | 3,738.5 | 4,056.1 | (317.6) | (8)% | |||
Other income | |||||||
Net investment income of Consolidated Funds | 117.9 | 24.0 | 93.9 | NM | |||
Income before provision for income taxes | 1,159.2 | 1,393.7 | (234.5) | (17)% | |||
Provision for income taxes | 214.5 | 302.6 | (88.1) | (29)% | |||
Net income | 944.7 | 1,091.1 | (146.4) | (13)% | |||
Net income attributable to non-controlling interests in consolidated entities | 136.0 | 70.7 | 65.3 | 92% | |||
Net income attributable to The Carlyle Group Inc. Common Stockholders | $808.7 | $1,020.4 | $(211.7) | (21)% | |||
Year Ended December 31, | |
2025 v. 2024 | |
(Dollars in millions) | |
Increase in management fees from the commencement of the investment period for certain newly raised funds which charge fees based on commitments and the impact of incremental fundraising in funds which activated fees in a prior period | $232.9 |
Net decrease in management fees resulting from the change in basis from commitments to invested capital and step-downs in rate for certain funds, and the impact of net investment activity in funds whose management fees are based on invested capital, including the impact of changes in the base under the strategic advisory services agreement with Fortitude | (132.8) |
Increase in catch-up management fees from subsequent closes of funds that are in the fundraising period | 46.8 |
Increase in transaction and portfolio advisory fees | 53.5 |
All other changes(1) | 8.1 |
Total increase in Fund management fees(2) | $208.5 |
Year Ended December 31, | Change | ||||||
2025 | 2024 | $ | % | ||||
(Dollars in millions) | |||||||
Performance allocations | $1,222.5 | $2,015.7 | $(793.2) | (39)% | |||
Principal investment income: | |||||||
Investment income from NGP, which includes performance allocations | (28.2) | 103.6 | (131.8) | (127)% | |||
Investment income from our carry funds: | |||||||
Global Private Equity | 40.4 | 35.3 | 5.1 | 14% | |||
Global Credit | 13.6 | 12.3 | 1.3 | 11% | |||
Carlyle AlpInvest | 14.0 | 6.4 | 7.6 | 119% | |||
Investment (loss) income from our CLOs | (15.9) | 23.0 | (38.9) | NM | |||
Investment income from Carlyle FRL | 29.8 | 33.8 | (4.0) | (12)% | |||
Investment income (loss) from our other Global Credit products | 15.4 | (4.8) | 20.2 | NM | |||
Investment income on foreign currency hedges | 2.1 | 4.0 | (1.9) | (48)% | |||
All other investment income (loss) | 48.0 | 25.1 | 22.9 | 91% | |||
Total Principal investment income | 119.2 | 238.7 | (119.5) | (50)% | |||
Total Investment income | $1,341.7 | $2,254.4 | $(912.7) | (40)% | |||
Year Ended December 31, | Change | ||||||
2025 | 2024 | $ | % | ||||
(Dollars in millions) | |||||||
Global Private Equity | $680.9 | $1,559.9 | $(879.0) | (56)% | |||
Global Credit | 282.6 | 227.7 | 54.9 | 24% | |||
Carlyle AlpInvest | 259.0 | 228.1 | 30.9 | 14% | |||
Total performance allocations | $1,222.5 | $2,015.7 | $(793.2) | (39)% | |||
Year Ended December 31, | Change | ||||||
2025 | 2024 | $ | % | ||||
(Dollars in millions) | |||||||
Realized gains (losses) | $28.3 | $(60.7) | $89.0 | NM | |||
Net change in unrealized gains (losses) | (11.9) | 157.1 | (169.0) | NM | |||
Total gains | 16.4 | 96.4 | (80.0) | (83)% | |||
Gains (losses) from liabilities of CLOs | 101.5 | (72.4) | 173.9 | NM | |||
Total net investment income of Consolidated Funds | $117.9 | $24.0 | $93.9 | NM | |||
Year Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Total Segment Revenues | $3,901.5 | $3,655.4 | |
Total Segment Expenses | 2,210.3 | 2,129.9 | |
(=) Distributable Earnings | $1,691.2 | $1,525.5 | |
(-) Realized Net Performance Revenues | 357.3 | 366.1 | |
(-) Realized Principal Investment Income | 151.8 | 101.0 | |
(+) Net Interest | 54.1 | 46.2 | |
(=) Fee Related Earnings | $1,236.2 | $1,104.6 | |
Year Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Segment Revenues | |||
Fund level fee revenues | |||
Fund management fees | $2,243.1 | $2,107.5 | |
Portfolio advisory and transaction fees, net and other | 225.1 | 163.6 | |
Fee related performance revenues | 174.5 | 132.7 | |
Total fund level fee revenues | 2,642.7 | 2,403.8 | |
Realized performance revenues | 1,037.4 | 1,075.9 | |
Realized principal investment income | 151.8 | 101.0 | |
Interest income | 69.6 | 74.7 | |
Total Segment Revenues | $3,901.5 | $3,655.4 | |
Year Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Segment Expenses | |||
Compensation and benefits | |||
Cash-based compensation and benefits | $902.1 | $861.7 | |
Realized performance revenue related compensation | 680.1 | 709.8 | |
Total compensation and benefits | 1,582.2 | 1,571.5 | |
General, administrative, and other indirect expenses | 450.4 | 390.7 | |
Depreciation and amortization expense | 54.0 | 46.8 | |
Interest expense | 123.7 | 120.9 | |
Total Segment Expenses | $2,210.3 | $2,129.9 | |
Year Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Income (loss) before provision for income taxes | $1,159.2 | $1,393.7 | |
Adjustments: | |||
Net unrealized performance and fee related performance revenues | (22.5) | (396.7) | |
Unrealized principal investment (income) loss | 19.4 | (34.1) | |
Equity-based compensation(1) | 376.6 | 476.5 | |
Acquisition or disposition-related charges, including amortization of intangibles and impairment | 262.4 | 136.6 | |
Tax (expense) benefit associated with certain foreign performance revenues | (0.5) | (1.0) | |
Net income attributable to non-controlling interests in consolidated entities | (136.0) | (70.7) | |
Other adjustments(2) | 32.6 | 21.2 | |
(=) Distributable Earnings | 1,691.2 | 1,525.5 | |
(-) Realized net performance revenues, net of related compensation(3) | 357.3 | 366.1 | |
(-) Realized principal investment income(3) | 151.8 | 101.0 | |
(+) Net interest | 54.1 | 46.2 | |
(=) Fee Related Earnings | $1,236.2 | $1,104.6 | |
Year Ended December 31, 2025 | |||||
Carlyle Consolidated | Adjustments(4) | Total Reportable Segments | |||
(Dollars in millions) | |||||
Performance revenues | $1,222.5 | $(185.1) | $1,037.4 | ||
Performance revenues related compensation expense | 936.3 | (256.2) | 680.1 | ||
Net performance revenues | $286.2 | $71.1 | $357.3 | ||
Principal investment income (loss) | $119.2 | $32.6 | $151.8 | ||
Year Ended December 31, 2024 | |||||
Carlyle Consolidated | Adjustments(4) | Total Reportable Segments | |||
(Dollars in millions) | |||||
Performance revenues | $2,015.7 | $(939.8) | $1,075.9 | ||
Performance revenues related compensation expense | 1,361.5 | (651.7) | 709.8 | ||
Net performance revenues | $654.2 | $(288.1) | $366.1 | ||
Principal investment income (loss) | $238.7 | $(137.7) | $101.0 | ||
Year Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Global Private Equity | $890.8 | $957.3 | |
Global Credit | 481.0 | 377.3 | |
Carlyle AlpInvest | 319.4 | 190.9 | |
Distributable Earnings | $1,691.2 | $1,525.5 | |
Year Ended December 31, | Change | ||||||
2025 | 2024 | $ | % | ||||
(Dollars in millions) | |||||||
Segment Revenues | |||||||
Fund level fee revenues | |||||||
Fund management fees | $1,176.3 | $1,212.0 | $(35.7) | (3)% | |||
Portfolio advisory and transaction fees, net and other | 39.0 | 24.6 | 14.4 | 59% | |||
Fee related performance revenues | 0.3 | 6.9 | (6.6) | (96)% | |||
Total fund level fee revenues | 1,215.6 | 1,243.5 | (27.9) | (2)% | |||
Realized performance revenues | 845.6 | 927.2 | (81.6) | (9)% | |||
Realized principal investment income | 56.3 | 49.7 | 6.6 | 13% | |||
Interest income | 28.7 | 28.1 | 0.6 | 2% | |||
Total revenues | 2,146.2 | 2,248.5 | (102.3) | (5)% | |||
Segment Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | 397.2 | 422.8 | (25.6) | (6)% | |||
Realized performance revenues related compensation | 540.4 | 590.1 | (49.7) | (8)% | |||
Total compensation and benefits | 937.6 | 1,012.9 | (75.3) | (7)% | |||
General, administrative, and other indirect expenses | 228.1 | 195.2 | 32.9 | 17% | |||
Depreciation and amortization expense | 29.4 | 26.8 | 2.6 | 10% | |||
Interest expense | 60.3 | 56.3 | 4.0 | 7% | |||
Total expenses | 1,255.4 | 1,291.2 | (35.8) | (3)% | |||
(=) Distributable Earnings | $890.8 | $957.3 | $(66.5) | (7)% | |||
(-) Realized net performance revenues | 305.2 | 337.1 | (31.9) | (9)% | |||
(-) Realized principal investment income | 56.3 | 49.7 | 6.6 | 13% | |||
(+) Net interest | 31.6 | 28.2 | 3.4 | 12% | |||
(=) Fee Related Earnings | $560.9 | $598.7 | $(37.8) | (6)% | |||
Year Ended December 31, | |
2025 v. 2024 | |
(Dollars in millions) | |
Distributable Earnings, December 31, 2024 | $957.3 |
Increases (decreases): | |
Decrease in Fee related earnings | (37.8) |
Decrease in Realized net performance revenues | (31.9) |
Increase in Realized principal investment income | 6.6 |
Increase in Net interest | (3.4) |
Total decrease | (66.5) |
Distributable Earnings, December 31, 2025 | $890.8 |
Year Ended December 31, | |
2025 v. 2024 | |
(Dollars in millions) | |
Fee Related Earnings, December 31, 2024 | $598.7 |
Increases (decreases): | |
Decrease in Fee revenues | (27.9) |
Decrease in Cash-based compensation and benefits | 25.6 |
Increase in General, administrative and other indirect expenses | (32.9) |
All other changes | (2.6) |
Total decrease | (37.8) |
Fee Related Earnings, December 31, 2025 | $560.9 |
Year Ended December 31, | |
2025 v. 2024 | |
(Dollars in millions) | |
Lower Fund management fees | $(35.7) |
Higher Portfolio advisory and transaction fees, net and other | 14.4 |
Lower Fee related performance revenues | (6.6) |
Total decrease in Fee revenues | $(27.9) |
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Global Private Equity | |||
Components of Fee-earning AUM(1) | |||
Fee-earning AUM based on capital commitments | $41,223 | $34,484 | |
Fee-earning AUM based on invested capital | 49,908 | 52,998 | |
Fee-earning AUM based on net asset value | 7,693 | 7,348 | |
Fee-earning AUM based on lower of cost or fair value | 2,542 | 3,203 | |
Total Fee-earning AUM | $101,366 | $98,033 | |
Annualized Management Fee Rate(2) | 1.17% | 1.17% | |
Year Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Global Private Equity | |||
Fee-earning AUM Rollforward | |||
Balance, Beginning of Period | $98,033 | $106,651 | |
Inflows(1) | 12,739 | 7,696 | |
Outflows (including realizations)(2) | (10,664) | (14,910) | |
Market Activity & Other(3) | (285) | (240) | |
Foreign Exchange(4) | 1,543 | (1,164) | |
Balance, End of Period | $101,366 | $98,033 | |
Year Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Global Private Equity | |||
Total AUM Rollforward | |||
Balance, Beginning of Period | $163,533 | $161,308 | |
Inflows(1) | 7,549 | 12,695 | |
Outflows (including realizations)(2) | (17,053) | (16,314) | |
Market Activity & Other(3) | 6,921 | 7,533 | |
Foreign Exchange(4) | 2,593 | (1,689) | |
Balance, End of Period | $163,543 | $163,533 | |
(Amounts in millions) | TOTAL INVESTMENTS | REALIZED/PARTIALLY REALIZED INVESTMENTS (12) | ||||||||||||
As of December 31, 2025 | As of December 31, 2025 | |||||||||||||
Fund (Fee Initiation Date/Step-down Date) (1) | Committed Capital (2) | Cumulative Invested Capital (3) | Percent Invested | Realized Value (4) | Remaining Fair Value (5) | MOIC (6) | Gross IRR (7)(8) | Net IRR (8)(9) | Net Accrued Carry/ (Giveback) (10) | Total Fair Value (11) | MOIC (6) | Gross IRR (7)(8) | ||
Corporate Private Equity | ||||||||||||||
CP VIII (Oct 2021 / Oct 2027) | $14,797 | $10,978 | 74% | $2,212 | $13,986 | 1.5x | 22% | 12% | $224 | $2,225 | 1.7x | 58% | ||
CP VII (May 2018 / Oct 2021) | $18,510 | $17,787 | 96% | $8,210 | $22,117 | 1.7x | 12% | 8% | $692 | $7,810 | 1.7x | 13% | ||
CP VI (May 2013 / May 2018) | $13,000 | $13,140 | 101% | $26,770 | $1,729 | 2.2x | 17% | 13% | $81 | $27,547 | 2.5x | 22% | ||
CP V (Jun 2007 / May 2013) | $13,720 | $13,238 | 96% | $28,120 | $336 | 2.1x | 18% | 14% | $23 | $28,131 | 2.3x | 20% | ||
CEP V (Oct 2018 / Oct 2024) | €6,416 | €6,067 | 95% | €1,794 | €4,582 | 1.1x | Neg | Neg | $— | €878 | 1.1x | 2% | ||
CEP IV (Sep 2014 / Oct 2018) | €3,670 | €3,964 | 108% | €6,215 | €1,269 | 1.9x | 16% | 11% | $50 | €6,258 | 2.1x | 20% | ||
CEP III (Jul 2007 / Dec 2013) | €5,295 | €5,177 | 98% | €11,731 | €18 | 2.3x | 19% | 14% | $2 | €11,749 | 2.3x | 19% | ||
CAP VI (Jun 2024 / Jun 2030) | $2,886 | $220 | 8% | $— | $220 | 1.0x | NM | NM | $— | n/a | n/a | n/a | ||
CAP V (Jun 2018 / Jun 2024) | $6,554 | $6,935 | 106% | $3,059 | $6,515 | 1.4x | 12% | 7% | $— | $2,142 | 1.3x | 23% | ||
CAP IV (Jul 2013 / Jun 2018) | $3,880 | $4,146 | 107% | $8,713 | $264 | 2.2x | 18% | 13% | $18 | $8,707 | 2.4x | 21% | ||
CJP V (Nov 2024 / Nov 2030) | ¥434,325 | ¥54,616 | 13% | ¥— | ¥54,757 | 1.0x | NM | NM | $— | n/a | n/a | n/a | ||
CJP IV (Oct 2020 / Nov 2024) | ¥258,000 | ¥236,110 | 92% | ¥148,550 | ¥341,724 | 2.1x | 38% | 26% | $100 | ¥198,217 | 3.8x | 66% | ||
CJP III (Sep 2013 / Aug 2020) | ¥119,505 | ¥91,192 | 76% | ¥275,264 | ¥8,832 | 3.1x | 25% | 18% | $4 | ¥274,341 | 3.3x | 26% | ||
CGFSP III (Dec 2017 / Dec 2023) | $1,005 | $982 | 98% | $697 | $1,567 | 2.3x | 21% | 15% | $73 | $1,210 | 3.7x | 32% | ||
CGFSP II (Jun 2013 / Dec 2017) | $1,000 | $943 | 94% | $1,961 | $650 | 2.8x | 26% | 19% | $37 | $1,956 | 2.4x | 28% | ||
CP Growth (Oct 2021 / Oct 2027) | $1,283 | $673 | 52% | $— | $831 | 1.2x | 10% | —% | $— | n/a | n/a | n/a | ||
CEOF II (Nov 2015 / Mar 2020) | $2,400 | $2,368 | 99% | $4,107 | $1,447 | 2.3x | 20% | 15% | $73 | $4,674 | 2.5x | 23% | ||
CETP V (Mar 2022 / Jun 2028) | €3,180 | €1,894 | 60% | €— | €2,297 | 1.2x | NM | NM | $— | n/a | n/a | n/a | ||
CETP IV (Jul 2019 / Jun 2022) | €1,350 | €1,204 | 89% | €1,726 | €1,040 | 2.3x | 29% | 20% | $45 | €1,847 | 3.7x | 56% | ||
CETP III (Jul 2014 / Jul 2019) | €657 | €614 | 94% | €2,033 | €81 | 3.4x | 40% | 28% | $5 | €2,039 | 4.0x | 44% | ||
CGP II (Dec 2020 / Jan 2025) | $1,840 | $984 | 53% | $203 | $1,972 | 2.2x | 24% | 19% | $47 | n/a | n/a | n/a | ||
CGP (Jan 2015 / Mar 2021) | $3,588 | $3,272 | 91% | $1,866 | $2,534 | 1.3x | 5% | 3% | $17 | $2,152 | 1.9x | 12% | ||
All Other Active Funds & Vehicles (13) | $20,873 | n/a | $15,807 | $17,765 | 1.6x | 12% | 10% | $35 | $15,637 | 2.0x | 18% | |||
Fully Realized Funds & Vehicles (14)(15) | $35,488 | n/a | $81,557 | $2 | 2.3x | 28% | 20% | $— | $81,559 | 2.3x | 28% | |||
TOTAL CORPORATE PRIVATE EQUITY (16) | $156,667 | n/a | $213,564 | $85,419 | 1.9x | 25% | 17% | $1,527 | $213,488 | 2.3x | 26% | |||
Real Estate | ||||||||||||||
CRP X (Apr 2025 / Jul 2030) | $9,000 | $668 | 7% | $— | $673 | 1.0x | NM | NM | $— | n/a | n/a | n/a | ||
CRP IX (Oct 2021 / Dec 2024) | $7,987 | $6,238 | 78% | $548 | $6,863 | 1.2x | 11% | 3% | $— | $468 | 1.4x | 24% | ||
CRP VIII (Aug 2017 / Oct 2021) | $5,505 | $5,091 | 92% | $5,880 | $2,960 | 1.7x | 31% | 17% | $76 | $5,906 | 2.1x | 47% | ||
CRP VII (Jun 2014 / Dec 2017) | $4,162 | $3,805 | 91% | $5,116 | $1,109 | 1.6x | 16% | 10% | $(16) | $5,102 | 1.7x | 20% | ||
CRP VI (Mar 2011 / Jun 2014) | $2,340 | $2,145 | 92% | $3,827 | $90 | 1.8x | 27% | 17% | $4 | $3,781 | 1.9x | 28% | ||
CPI (May 2016 / n/a) | $8,445 | $8,910 | 106% | $3,609 | $8,061 | 1.3x | 10% | 8% | n/a* | $2,193 | 1.8x | 12% | ||
All Other Active Funds & Vehicles (17) | $2,618 | n/a | $535 | $2,517 | 1.2x | 9% | 5% | $5 | $366 | 1.1x | 22% | |||
Fully Realized Funds & Vehicles (15)(18) | $14,289 | n/a | $21,640 | $13 | 1.5x | 9% | 5% | $— | $21,653 | 1.5x | 10% | |||
TOTAL REAL ESTATE (16) | $43,763 | n/a | $41,155 | $22,285 | 1.4x | 11% | 7% | $70 | $39,469 | 1.6x | 13% | |||
Infrastructure & Natural Resources | ||||||||||||||
CIEP II (Apr 2019 / Apr 2025) | $2,286 | $1,301 | 57% | $991 | $1,389 | 1.8x | 28% | 14% | $46 | $882 | 3.7x | NM** | ||
CIEP I (Sep 2013 / Jun 2019) | $2,500 | $2,470 | 99% | $3,570 | $1,224 | 1.9x | 15% | 9% | $51 | $3,974 | 2.0x | 16% | ||
CGIOF (Dec 2018 / Sep 2023) | $2,201 | $2,091 | 95% | $658 | $3,074 | 1.8x | 19% | 12% | $93 | $806 | 1.8x | 16% | ||
CRSEF II (Nov 2022 / Aug 2027) | $1,187 | $472 | 40% | $— | $918 | 1.9x | NM | NM | $23 | n/a | n/a | n/a | ||
NGP XIII (Feb 2023 / Feb 2028) | $2,300 | $905 | 39% | $87 | $1,163 | 1.4x | NM | NM | $5 | $99 | 3.2x | NM | ||
NGP XII (Jul 2017 / Jul 2022) | $4,304 | $3,665 | 85% | $4,871 | $2,674 | 2.1x | 21% | 15% | $32 | $4,472 | 2.7x | 33% | ||
NGP XI (Oct 2014 / Jul 2017) | $5,325 | $5,034 | 95% | $8,269 | $1,579 | 2.0x | 13% | 10% | $57 | $7,392 | 2.1x | 17% | ||
NGP X (Jan 2012 / Dec 2014) | $3,586 | $3,351 | 93% | $3,561 | $207 | 1.1x | 3% | —% | $— | $3,358 | 1.2x | 5% | ||
All Other Active Funds & Vehicles (19) | $5,168 | n/a | $3,396 | $4,998 | 1.6x | 15% | 12% | $38 | $3,312 | 2.2x | 18% | |||
Fully Realized Funds & Vehicles (15)(20) | $3,534 | n/a | $5,581 | $— | 1.6x | 8% | 5% | $— | $5,581 | 1.6x | 8% | |||
TOTAL INFRASTRUCTURE & NATURAL RESOURCES (16) | $27,990 | n/a | $30,983 | $17,227 | 1.7x | 12% | 8% | $343 | $29,874 | 1.9x | 14% | |||
Year Ended December 31, | Change | ||||||
2025 | 2024 | $ | % | ||||
(Dollars in millions) | |||||||
Segment Revenues | |||||||
Fund level fee revenues | |||||||
Fund management fees | $609.1 | $558.3 | $50.8 | 9% | |||
Portfolio advisory and transaction fees, net and other | 185.8 | 138.8 | 47.0 | 34% | |||
Fee related performance revenues | 115.2 | 109.1 | 6.1 | 6% | |||
Total fund level fee revenues | 910.1 | 806.2 | 103.9 | 13% | |||
Realized performance revenues | 98.0 | 32.0 | 66.0 | 206% | |||
Realized principal investment income | 59.4 | 46.2 | 13.2 | 29% | |||
Interest income | 31.6 | 39.0 | (7.4) | (19)% | |||
Total revenues | 1,099.1 | 923.4 | 175.7 | 19% | |||
Segment Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | 351.9 | 320.1 | 31.8 | 10% | |||
Realized performance revenues related compensation | 59.9 | 19.4 | 40.5 | 209% | |||
Total compensation and benefits | 411.8 | 339.5 | 72.3 | 21% | |||
General, administrative, and other indirect expenses | 140.3 | 140.4 | (0.1) | —% | |||
Depreciation and amortization expense | 16.4 | 13.2 | 3.2 | 24% | |||
Interest expense | 49.6 | 53.0 | (3.4) | (6)% | |||
Total expenses | 618.1 | 546.1 | 72.0 | 13% | |||
(=) Distributable Earnings | $481.0 | $377.3 | $103.7 | 27% | |||
(-) Realized Net Performance Revenues | 38.1 | 12.6 | 25.5 | 202% | |||
(-) Realized Principal Investment Income | 59.4 | 46.2 | 13.2 | 29% | |||
(+) Net Interest | 18.0 | 14.0 | 4.0 | 29% | |||
(=) Fee Related Earnings | $401.5 | $332.5 | $69.0 | 21% | |||
Year Ended December 31, | |
2025 v. 2024 | |
(Dollars in millions) | |
Distributable Earnings, December 31, 2024 | $377.3 |
Increases (decreases): | |
Increase in Fee related earnings | 69.0 |
Increase in Realized net performance revenues | 25.5 |
Increase in Realized principal investment income | 13.2 |
Increase in Net interest | (4.0) |
Total increase | 103.7 |
Distributable Earnings, December 31, 2025 | $481.0 |
Year Ended December 31, | |
2025 v. 2024 | |
(Dollars in millions) | |
Fee Related Earnings, December 31, 2024 | $332.5 |
Increases (Decreases): | |
Increase in Fee revenues | 103.9 |
Increase in Cash-based compensation and benefits | (31.8) |
Decrease in General, administrative and other indirect expenses | 0.1 |
All other changes | (3.2) |
Total increase | 69.0 |
Fee Related Earnings, December 31, 2025 | $401.5 |
Year Ended December 31, | |
2025 v. 2024 | |
(Dollars in millions) | |
Higher Fund management fees | $50.8 |
Higher Portfolio advisory and transaction fees, net and other | 47.0 |
Higher Fee related performance revenues | 6.1 |
Total increase in Fee revenues | $103.9 |
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Global Credit | |||
Components of Fee-earning AUM(1) | |||
Fee-earning AUM based on capital commitments | $2,504 | $2,467 | |
Fee-earning AUM based on invested capital | 21,784 | 19,604 | |
Fee-earning AUM based on collateral balances, at par | 44,455 | 45,890 | |
Fee-earning AUM based on net asset value | 4,185 | 3,091 | |
Fee-earning AUM based on fair value and other(2) | 96,532 | 83,134 | |
Total Fee-earning AUM | $169,460 | $154,186 | |
Annualized Management Fee Rate(3) | 0.36% | 0.36% | |
Year Ended Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Global Credit | |||
Fee-earning AUM Rollforward | |||
Balance, Beginning of Period | $154,186 | $155,238 | |
Inflows(1) | 26,806 | 15,389 | |
Outflows (including realizations)(2) | (13,863) | (12,520) | |
Market Activity & Other(3) | 1,212 | (3,290) | |
Foreign Exchange(4) | 1,119 | (631) | |
Balance, End of Period | $169,460 | $154,186 | |
Year Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Global Credit | |||
Total AUM Rollforward | |||
Balance, Beginning of Period | $192,374 | $187,826 | |
Inflows(1) | 28,254 | 17,274 | |
Outflows (including realizations)(2) | (15,996) | (13,172) | |
Market Activity & Other(3) | 5,481 | 1,110 | |
Foreign Exchange(4) | 1,215 | (664) | |
Balance, End of Period | $211,328 | $192,374 | |
(Dollars in millions) | TOTAL INVESTMENTS | |||||||||
As of December 31, 2025 | ||||||||||
Fund (Fee Initiation Date/Step-down Date) (11) | Committed Capital (12) | Cumulative Invested Capital (1) | Percent Invested | Realized Value (2) | Remaining Fair Value (3) | MOIC (4) | Gross IRR (5)(8) | Net IRR (6)(8) | Net Accrued Carry/(Giveback) (7) | |
Global Credit Carry Funds | ||||||||||
CCOF III - Levered (Feb 2023 / Oct 2028) | $4,678 | $3,976 | 85% | $784 | $3,882 | 1.2x | 27% | 17% | $23 | |
CCOF II (Nov 2020 / Mar 2026) | $4,430 | $5,880 | 133% | $4,056 | $4,125 | 1.4x | 14% | 10% | $109 | |
CCOF I (Nov 2017 / Sep 2022) | $2,373 | $3,514 | 148% | $3,890 | $1,230 | 1.5x | 16% | 12% | $30 | |
CSP IV (Apr 2016 / Dec 2020) | $2,500 | $2,500 | 100% | $1,755 | $1,786 | 1.4x | 10% | 5% | $— | |
CICF II (Mar 2024 / Dec 2029) | $1,379 | $310 | 22% | $57 | $280 | 1.1x | NM | NM | $— | |
SASOF III (Nov 2014 / n/a) | $833 | $991 | 119% | $1,277 | $84 | 1.4x | 19% | 12% | $6 | |
All Other Active Funds & Vehicles (9) | $12,836 | n/a | $5,476 | $10,662 | 1.3x | 11% | 9% | $95 | ||
Fully Realized Funds & Vehicles (10)(13) | $9,698 | n/a | $12,156 | $32 | 1.3x | 9% | 4% | $— | ||
TOTAL GLOBAL CREDIT CARRY FUNDS | $39,705 | n/a | $29,451 | $22,081 | 1.3x | 11% | 7% | $263 | ||
Year Ended December 31, | Change | ||||||
2025 | 2024 | $ | % | ||||
(Dollars in millions) | |||||||
Segment Revenues | |||||||
Fund level fee revenues | |||||||
Fund management fees | $457.7 | $337.2 | $120.5 | 36% | |||
Portfolio advisory and transaction fees, net and other | 0.3 | 0.2 | 0.1 | 50% | |||
Fee related performance revenues | 59.0 | 16.7 | 42.3 | 253% | |||
Total fund level fee revenues | 517.0 | 354.1 | 162.9 | 46% | |||
Realized performance revenues | 93.8 | 116.7 | (22.9) | (20)% | |||
Realized principal investment income | 36.1 | 5.1 | 31.0 | NM | |||
Interest income | 9.3 | 7.6 | 1.7 | 22% | |||
Total revenues | 656.2 | 483.5 | 172.7 | 36% | |||
Segment Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | 153.0 | 118.8 | 34.2 | 29% | |||
Realized performance revenues related compensation | 79.8 | 100.3 | (20.5) | (20)% | |||
Total compensation and benefits | 232.8 | 219.1 | 13.7 | 6% | |||
General, administrative, and other indirect expenses | 82.0 | 55.1 | 26.9 | 49% | |||
Depreciation and amortization expense | 8.2 | 6.8 | 1.4 | 21% | |||
Interest expense | 13.8 | 11.6 | 2.2 | 19% | |||
Total expenses | 336.8 | 292.6 | 44.2 | 15% | |||
(=) Distributable Earnings | $319.4 | $190.9 | $128.5 | 67% | |||
(-) Realized Net Performance Revenues | 14.0 | 16.4 | (2.4) | (15)% | |||
(-) Realized Principal Investment Income | 36.1 | 5.1 | 31.0 | NM | |||
(+) Net Interest | 4.5 | 4.0 | 0.5 | 13% | |||
(=) Fee Related Earnings | $273.8 | $173.4 | $100.4 | 58% | |||
Year Ended December 31, | |
2025 v. 2024 | |
(Dollars in millions) | |
Distributable Earnings, December 31, 2024 | $190.9 |
Increases (decreases): | |
Increase in Fee related earnings | 100.4 |
Decrease in Realized net performance revenues | (2.4) |
Increase in Realized principal investment income | 31.0 |
Increase in Net interest | (0.5) |
Total increase | 128.5 |
Distributable Earnings, December 31, 2025 | $319.4 |
Year Ended December 31, | |
2025 v. 2024 | |
(Dollars in millions) | |
Fee Related Earnings, December 31, 2024 | $173.4 |
Increases (decreases): | |
Increase in Fee revenues | 162.9 |
Increase in Cash-based compensation and benefits | (34.2) |
Increase in General, administrative and other indirect expenses | (26.9) |
All other changes | (1.4) |
Total increase | 100.4 |
Fee Related Earnings, December 31, 2025 | $273.8 |
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Carlyle AlpInvest | |||
Components of Fee-earning AUM(1) | |||
Fee-earning AUM based on capital commitments | $27,884 | $21,934 | |
Fee-earning AUM based on invested capital(2) | 9,122 | 9,224 | |
Fee-earning AUM based on net asset value | 18,273 | 12,930 | |
Fee-earning AUM based on lower of cost or fair market value | 10,673 | 8,051 | |
Total Fee-earning AUM | $65,952 | $52,139 | |
Annualized Management Fee Rate(3) | 0.68% | 0.66% | |
Year Ended Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Carlyle AlpInvest | |||
Fee-earning AUM Rollforward | |||
Balance, Beginning of Period | $52,139 | $45,529 | |
Inflows(1) | 16,039 | 9,886 | |
Outflows (including realizations)(2) | (5,260) | (3,859) | |
Market Activity & Other(3) | 918 | 1,674 | |
Foreign Exchange(4) | 2,116 | (1,091) | |
Balance, End of Period | $65,952 | $52,139 | |
Year Ended Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Carlyle AlpInvest | |||
Total AUM Rollforward | |||
Balance, Beginning of Period | $85,113 | $76,860 | |
Inflows(1) | 17,889 | 10,812 | |
Outflows (including realizations)(2) | (10,231) | (7,089) | |
Market Activity & Other(3) | 5,644 | 6,577 | |
Foreign Exchange(4) | 3,581 | (2,047) | |
Balance, End of Period | $101,996 | $85,113 | |
(Amounts in millions) | TOTAL INVESTMENTS | ||||||||||
As of December 31, 2025 | |||||||||||
Carlyle AlpInvest (1)(8) | Vintage Year | Fund Size | Cumulative Invested Capital (2)(3) | Realized Value (3) | Remaining Fair Value (3) | Total Value (3)(4) | MOIC (5) | Gross IRR (6)(10) | Net IRR (7)(10) | Net Accrued Carry/ (Giveback) (12) | |
(Reported in Local Currency, in Millions) | |||||||||||
Secondaries & Portfolio Finance | ASF VIII | 2024 | $13,422 | $6,597 | $278 | $8,191 | $8,469 | 1.3x | NM | NM | $59 |
ASF VII | 2020 | $6,769 | $4,991 | $2,484 | $5,431 | $7,914 | 1.6x | 17% | 13% | $118 | |
ASF VII - SMAs | 2020 | €2,043 | €1,721 | €662 | €1,903 | €2,565 | 1.5x | 15% | 13% | $38 | |
ASF VI | 2017 | $3,333 | $2,820 | $3,116 | $1,547 | $4,663 | 1.7x | 15% | 11% | $58 | |
ASF VI - SMAs | 2017 | €2,817 | €2,626 | €2,717 | €1,497 | €4,214 | 1.6x | 13% | 11% | $49 | |
ASF V | 2012 | $756 | $674 | $1,091 | $110 | $1,201 | 1.8x | 18% | 14% | $5 | |
ASF V - SMAs | 2012 | €3,916 | €3,922 | €6,857 | €407 | €7,264 | 1.9x | 21% | 19% | $9 | |
SMAs 2009-2011 | 2010 | €1,859 | €1,931 | €3,334 | €33 | €3,367 | 1.7x | 19% | 18% | $— | |
ASPF II | 2023 | $2,227 | $1,379 | $274 | $1,282 | $1,556 | 1.1x | 24% | 17% | $8 | |
All Other Active Funds & Vehicles (9) | Various | $1,803 | $479 | $2,049 | $2,528 | 1.4x | 19% | 16% | $36 | ||
Fully Realized Funds & Vehicles | Various | €4,341 | €7,074 | €12 | €7,087 | 1.6x | 19% | 18% | $— | ||
Co-Investments | ACF IX | 2023 | $4,120 | $2,120 | $19 | $2,426 | $2,445 | 1.2x | 15% | 9% | $4 |
ACF VIII | 2021 | $3,614 | $3,469 | $455 | $4,487 | $4,941 | 1.4x | 11% | 9% | $48 | |
ACF VIII - SMAs | 2021 | $1,099 | $1,011 | $135 | $1,289 | $1,424 | 1.4x | 12% | 10% | $12 | |
ACF VII | 2017 | $1,688 | $1,691 | $1,718 | $1,628 | $3,346 | 2.0x | 14% | 12% | $58 | |
ACF VII - SMAs | 2017 | €1,452 | €1,381 | €1,173 | €1,404 | €2,577 | 1.9x | 14% | 12% | $42 | |
SMAs 2014-2016 | 2014 | €1,274 | €1,064 | €2,424 | €288 | €2,713 | 2.6x | 24% | 22% | $6 | |
SMAs 2012-2013 | 2012 | €1,124 | €1,009 | €2,764 | €129 | €2,893 | 2.9x | 28% | 26% | $1 | |
SMAs 2009-2010 | 2010 | €1,475 | €1,317 | €3,496 | €409 | €3,905 | 3.0x | 23% | 21% | $— | |
Strategic SMAs | Various | $4,872 | $2,642 | $5,472 | $8,115 | 1.7x | 16% | 14% | $79 | ||
All Other Active Funds & Vehicles (9) | Various | €345 | €167 | €328 | €495 | 1.4x | 32% | 30% | $2 | ||
Fully Realized Funds & Vehicles | Various | €5,788 | €9,904 | €— | €9,905 | 1.7x | 15% | 13% | $— | ||
Primary Investments | SMAs 2024-2026 | 2024 | €3,475 | €202 | €6 | €199 | €204 | 1.0x | NM | NM | $— |
SMAs 2021-2023 | 2021 | €4,583 | €1,816 | €152 | €2,042 | €2,194 | 1.2x | NM | NM | $1 | |
SMAs 2018-2020 | 2018 | $3,116 | $2,661 | $843 | $3,170 | $4,013 | 1.5x | 14% | 13% | $4 | |
SMAs 2015-2017 | 2015 | €2,501 | €2,465 | €2,838 | €2,061 | €4,900 | 2.0x | 19% | 18% | $9 | |
SMAs 2012-2014 | 2012 | €5,080 | €5,704 | €9,650 | €2,801 | €12,452 | 2.2x | 17% | 17% | $11 | |
SMAs 2009-2011 | 2009 | €4,877 | €5,527 | €10,423 | €1,532 | €11,955 | 2.2x | 17% | 16% | $1 | |
SMAs 2006-2008 | 2005 | €11,500 | €12,836 | €21,532 | €1,058 | €22,591 | 1.8x | 10% | 10% | $— | |
SMAs 2003-2005 | 2003 | €4,628 | €4,883 | €7,775 | €131 | €7,906 | 1.6x | 10% | 9% | $— | |
All Other Active Funds & Vehicles (9) | Various | €1,744 | €1,767 | €218 | €1,986 | 1.1x | 3% | 2% | $— | ||
Fully Realized Funds & Vehicles | Various | €4,744 | €7,735 | €18 | €7,753 | 1.6x | 12% | 11% | $— | ||
TOTAL CARLYLE ALPINVEST (USD) (11) | $110,807 | $133,782 | $56,414 | $190,196 | 1.7x | 14% | 13% | $656 | |||
Accrued Performance Allocations(1) | Accrued Giveback Obligation | Net Accrued Performance Revenues | |||
(Dollars in millions) | |||||
Global Private Equity | $5,021.1 | $(47.3) | $4,973.8 | ||
Global Credit | 724.6 | (25.5) | 699.1 | ||
Carlyle AlpInvest | 1,874.6 | — | 1,874.6 | ||
Total | $7,620.3 | $(72.8) | $7,547.5 | ||
Plus: Accrued performance allocations from NGP Carry Funds(2) | 326.2 | ||||
Less: Accrued performance allocation-related compensation | (5,064.7) | ||||
Plus: Receivable for giveback obligations from current and former employees | 24.2 | ||||
Less: Deferred taxes on certain foreign accrued performance allocations | (16.0) | ||||
Less/Plus: Net accrued performance allocations/giveback obligations attributable to non-controlling interests in consolidated entities | (0.6) | ||||
Plus: Net accrued performance allocations attributable to Consolidated Funds, eliminated in consolidation | 19.6 | ||||
Net accrued performance revenues before timing differences | 2,836.2 | ||||
Less/Plus: Timing differences between the period when accrued performance allocations/giveback obligations are realized and the period they are collected/distributed | 23.1 | ||||
Net accrued performance revenues attributable to The Carlyle Group Inc. | $2,859.3 | ||||
Carry Fund Appreciation/(Depreciation)(1) | Net Accrued Performance Revenues | |||||||
FY 2023 | FY 2024 | FY 2025 | ||||||
Overall Carry Fund Appreciation/(Depreciation) | 7% | 8% | 8% | |||||
Global Private Equity: | 5% | 7% | 7% | $1,940.4 | ||||
Corporate Private Equity | 5% | 8% | 7% | 1,527.1 | ||||
Real Estate | (1)% | 5% | 3% | 69.9 | ||||
Infrastructure & Natural Resources | 8% | 8% | 17% | 343.4 | ||||
Global Credit Carry Funds | 12% | 12% | 16% | 262.9 | ||||
Carlyle AlpInvest Carry Funds | 10% | 9% | 6% | 656.0 | ||||
Net Accrued Performance Revenues | $2,859.3 | |||||||
Investments in Carlyle Funds | Investments in NGP(1) | Total | |||
(Dollars in millions) | |||||
Investments, excluding performance allocations | $2,916.4 | $616.0 | $3,532.4 | ||
Less: Amounts attributable to non-controlling interests in consolidated entities | (388.3) | — | (388.3) | ||
Plus: Investments in Consolidated Funds, eliminated in consolidation | 1,047.3 | — | 1,047.3 | ||
Less: Strategic equity method investments in NGP Management | — | (247.4) | (247.4) | ||
Less: Investment in NGP general partners - accrued performance allocations | — | (326.2) | (326.2) | ||
Total investments attributable to The Carlyle Group Inc. | $3,575.4 | $42.4 | $3,617.8 | ||
Investments in Carlyle Funds, excluding CLOs: | |
Global Private Equity funds(1) | $1,334.0 |
Global Credit funds(2) | 1,346.3 |
Carlyle AlpInvest funds | 391.9 |
Total investments in Carlyle Funds, excluding CLOs | 3,072.2 |
Investments in CLOs | 419.0 |
Other investments | 126.6 |
Total investments attributable to The Carlyle Group Inc. | 3,617.8 |
CLO loans and other borrowings collateralized by investments attributable to The Carlyle Group Inc.(3) | (330.7) |
Total investments attributable to The Carlyle Group Inc., net of CLO loans and other borrowings | $3,287.1 |
Common Stock Dividends - Dividend Year 2025 | ||||
Quarter | Dividend per Common Share | Dividend to Common Stockholders | Record Date | Payment Date |
(Dollars in millions, except per share data) | ||||
Q1 2025 | $0.35 | $126.3 | May 19, 2025 | May 27, 2025 |
Q2 2025 | 0.35 | 126.5 | August 18, 2025 | August 28, 2025 |
Q3 2025 | 0.35 | 125.9 | November 10, 2025 | November 19, 2025 |
Q4 2025 | 0.35 | 126.4 | February 16, 2026 | February 20, 2026 |
Total | $1.40 | $505.1 | ||
Common Stock Dividends - Dividend Year 2024 | ||||
Quarter | Dividend per Common Share | Dividend to Common Stockholders | Record Date | Payment Date |
(Dollars in millions, except per share data) | ||||
Q1 2024 | $0.35 | $125.6 | May 14, 2024 | May 21, 2024 |
Q2 2024 | 0.35 | 125.5 | August 16, 2024 | August 26, 2024 |
Q3 2024 | 0.35 | 125.2 | November 18, 2024 | November 25, 2024 |
Q4 2024 | 0.35 | 126.4 | February 21, 2025 | February 28, 2025 |
Total | $1.40 | $502.7 | ||
Year Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Statements of Cash Flows Data | |||
Net cash provided by the Company’s operating activities | $1,088.6 | $1,088.9 | |
Net cash used in the Consolidated Funds’ operating activities, after eliminations | (4,364.1) | (1,848.4) | |
Net cash used in operating activities | (3,275.5) | (759.5) | |
Net cash used in investing activities | (99.4) | (77.6) | |
Net cash used in the Company’s financing activities | (327.2) | (1,172.1) | |
Net cash provided by the Consolidated Funds’ financing activities, after eliminations | 4,317.6 | 1,854.9 | |
Net cash provided by financing activities | 3,990.4 | 682.8 | |
Effect of foreign exchange rate changes | 91.6 | (21.3) | |
Net change in cash, cash equivalents and restricted cash | $707.1 | $(175.6) | |
2026 | 2027-2028 | 2029-2030 | Thereafter | Total | |||||
(Dollars in millions) | |||||||||
Debt obligations(1) | $55.5 | $128.9 | $447.0 | $2,393.7 | $3,025.1 | ||||
Interest payable(2) | 147.6 | 288.1 | 261.1 | 1,662.8 | 2,359.6 | ||||
Other consideration(3) | 18.3 | 5.6 | — | — | 23.9 | ||||
Operating lease obligations(4) | 74.6 | 149.8 | 132.9 | 197.8 | 555.1 | ||||
Capital commitments to Carlyle funds(5) | 3,908.1 | — | — | — | 3,908.1 | ||||
Tax receivable agreement payments(6) | 8.2 | 8.0 | 14.8 | 40.8 | 71.8 | ||||
Loans payable of Consolidated Funds(7) | 412.9 | 826.9 | 825.7 | 12,092.5 | 14,158.0 | ||||
Unfunded commitments of the CLOs(8) | 21.0 | — | — | — | 21.0 | ||||
Consolidated contractual obligations | 4,646.2 | 1,407.3 | 1,681.5 | 16,387.6 | 24,122.6 | ||||
Loans payable of Consolidated Funds(7) | (412.9) | (826.9) | (825.7) | (12,092.5) | (14,158.0) | ||||
Capital commitments to Carlyle funds(5) | (3,256.4) | — | — | — | (3,256.4) | ||||
Unfunded commitments of the CLOs(8) | (21.0) | — | — | — | (21.0) | ||||
Carlyle Operating Entities contractual obligations | $955.9 | $580.4 | $855.8 | $4,295.1 | $6,687.2 | ||||
Year Ended Ended December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Balance, beginning of period | 357,183,632 | 361,326,172 | |
Shares issued | 7,714,141 | 4,842,417 | |
Shares repurchased/retired | (7,523,750) | (8,984,957) | |
Balance, end of period | 357,374,023 | 357,183,632 | |
10% Increase in Total Remaining Fair Value | 10% Decrease in Total Remaining Fair Value | ||
(Dollars in millions) | |||
Global Private Equity | $2,030.7 | $(2,797.7) | |
Global Credit | 245.6 | (287.7) | |
Carlyle AlpInvest | 448.0 | (505.9) | |
Total | $2,724.3 | $(3,591.3) | |
Remaining Fair Value | |
(Dollars in millions) | |
Global Private Equity | $124,800 |
Global Credit | $191,995 |
Carlyle AlpInvest | $72,399 |
Description of the Matter | At December 31, 2025, the carrying value of the Company’s investments totaled approximately $11.2 billion. As discussed in Notes 2 and 4 to the consolidated financial statements, a significant input to the measurement of the Company’s principal equity method investments in the funds and accrued performance allocations, is management’s estimate of the fair value of the investments held by each fund. Management estimates the fair value of the funds’ investments, including investments in the equity of private operating companies, real estate properties and certain debt positions, by applying the methodologies outlined in Notes 2 and 4 and using unobservable inputs and assumptions. Auditing management’s estimates of the fair value of certain of the funds’ investments using significant unobservable inputs and assumptions was complex and judgmental because these investments exhibit higher estimation uncertainty. |
How We Addressed the Matter in Our Audit | We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over the funds’ investment valuation process. This included management's review controls over the assessment of the methodologies, significant inputs and assumptions included in the fair value estimates, as well as management’s review around the completeness, accuracy and reasonableness of the data used in these estimates. Our audit procedures related to a sample of investment valuations using significant unobservable inputs included, among others, assessing whether the valuation methodologies used were appropriate and testing the mathematical accuracy of the valuation models. For a sample of investment valuations, we obtained management’s valuation models and compared objective inputs used in the models to agreements or underlying source documents provided by the Company. We assessed the appropriateness of certain unobservable inputs and assumptions used in the valuation models by comparing them to underlying support or available market data and evaluating the appropriateness of adjustments. Our procedures varied based on the nature of the investment selected for testing. For example, for certain investments in the equity of private operating companies, we assessed the appropriateness of management’s determination of public market comparable companies and similar transactions. For these selected investments, we also evaluated adjustments applied to the selected earnings before interest, taxes, depreciation and amortization (EBITDA) multiple or discount rate derived from the comparable companies by considering investee specific and relevant market information. For certain investments, we independently developed fair value estimates, with the support of valuation specialists, using investee and market information and compared them to the funds’ fair value estimates. For a sample of investments that were sold during the year, we performed procedures to assess the historical reasonableness of management’s estimates. We also evaluated subsequent events and transactions and considered whether they corroborated or contradicted the year- end estimates. |
December 31, | |||
2025 | 2024 | ||
Assets | |||
Cash and cash equivalents | $ | $ | |
Cash and cash equivalents held at Consolidated Funds | |||
Investments, including accrued performance allocations of $ 2025 and 2024, respectively | |||
Investments of Consolidated Funds | |||
Due from affiliates and other receivables, net | |||
Due from affiliates and other receivables of Consolidated Funds, net | |||
Fixed assets, net | |||
Lease right-of-use assets, net | |||
Deposits and other | |||
Intangible assets, net | |||
Deferred tax assets | |||
Total assets | $ | $ | |
Liabilities and equity | |||
Debt obligations | $ | $ | |
Loans payable of Consolidated Funds | |||
Accounts payable, accrued expenses and other liabilities | |||
Accrued compensation and benefits | |||
Due to affiliates | |||
Deferred revenue | |||
Deferred tax liabilities | |||
Other liabilities of Consolidated Funds | |||
Lease liabilities | |||
Accrued giveback obligations | |||
Total liabilities | |||
Commitments and contingencies | |||
Common stock, $ shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively) | |||
Additional paid-in capital | |||
Retained earnings | |||
Accumulated other comprehensive loss | ( | ( | |
Non-controlling interests in consolidated entities | |||
Total equity | |||
Total liabilities and equity | $ | $ | |
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
Revenues | |||||
Fund management fees | $ | $ | $ | ||
Incentive fees | |||||
Investment income | |||||
Performance allocations | ( | ||||
Principal investment income | |||||
Total investment income | |||||
Interest and other income | |||||
Interest and other income of Consolidated Funds | |||||
Total revenues | |||||
Expenses | |||||
Compensation and benefits | |||||
Cash-based compensation and benefits | |||||
Equity-based compensation | |||||
Performance allocations and incentive fee related compensation | |||||
Total compensation and benefits | |||||
General, administrative and other expenses | |||||
Interest | |||||
Interest and other expenses of Consolidated Funds | |||||
Other non-operating (income) expenses | ( | ( | |||
Total expenses | |||||
Other income | |||||
Net investment income of Consolidated Funds | |||||
Income (loss) before provision for income taxes | ( | ||||
Provision (benefit) for income taxes | ( | ||||
Net income (loss) | ( | ||||
Net income attributable to non-controlling interests in consolidated entities | |||||
Net income (loss) attributable to The Carlyle Group Inc. | $ | $ | $( | ||
Net income (loss) attributable to The Carlyle Group Inc. per common share (see Note 12) | |||||
Basic | $ | $ | $( | ||
Diluted | $ | $ | $( | ||
Weighted-average common shares | |||||
Basic | |||||
Diluted | |||||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
Net income (loss) | $ | $ | $( | ||
Other comprehensive income (loss), net of tax | |||||
Foreign currency translation adjustments, net of income tax (benefit) expense of $( $( | ( | ||||
Defined benefit plans, net | |||||
Unrealized net income (loss) for the period, net of income tax (benefit) expense of $ respectively | ( | ||||
Less: reclassification adjustment for unrecognized loss during the period included in base compensation expense, net of income tax benefit of $( $( | ( | ( | ( | ||
Other comprehensive income (loss) | ( | ||||
Comprehensive income (loss) | ( | ||||
Comprehensive income attributable to non-controlling interests in consolidated entities | |||||
Comprehensive income (loss) attributable to The Carlyle Group Inc. | $ | $ | $( | ||
Common Shares | Common Stock | Additional Paid-in Capital | Retained Earnings (Deficit) | Accumulated Other Comprehensive Income (Loss) | Non-controlling Interests in Consolidated Entities | Total Equity | |||||||
Balance at December 31, 2022 | $ | $ | $ | $( | $ | $ | |||||||
Shares repurchased | ( | — | — | ( | — | — | ( | ||||||
Net shares issued for equity-based awards | — | — | — | — | — | — | |||||||
Equity-based compensation | — | — | — | — | — | ||||||||
Dividend-equivalent rights on certain equity- based awards | — | — | ( | — | — | ||||||||
Contributions | — | — | — | — | — | ||||||||
Dividends and distributions | — | — | — | ( | — | ( | ( | ||||||
Net income (loss) | — | — | — | ( | — | ( | |||||||
Deconsolidation of Consolidated Entities | — | — | — | — | — | ( | ( | ||||||
Currency translation adjustments | — | — | — | — | |||||||||
Defined benefit plans, net | — | — | — | — | ( | — | ( | ||||||
Balance at December 31, 2023 | $ | $ | $ | $( | $ | $ | |||||||
Shares repurchased | ( | ( | — | ( | — | — | ( | ||||||
Net shares issued for equity-based awards | — | — | ( | — | — | ( | |||||||
Equity-based compensation | — | — | — | — | |||||||||
Dividend-equivalent rights on certain equity- based awards | — | — | ( | — | — | ||||||||
Contributions | — | — | — | — | — | ||||||||
Dividends and distributions | — | — | — | ( | — | ( | ( | ||||||
Net income | — | — | — | — | |||||||||
Change in ownership of a Consolidated Entity | — | — | — | — | ( | ||||||||
Deconsolidation of Consolidated Entities | — | — | — | — | — | ( | ( | ||||||
Currency translation adjustments | — | — | — | — | ( | ( | ( | ||||||
Defined benefit plans, net | — | — | — | — | — | ||||||||
Balance at December 31, 2024 | $ | $ | $ | $( | $ | $ | |||||||
Shares repurchased | ( | ( | — | ( | — | — | ( | ||||||
Net shares issued for equity-based awards | — | — | ( | — | — | ( | |||||||
Equity-based compensation | — | — | — | — | |||||||||
Dividend-equivalent rights on certain equity- based awards | — | — | ( | — | — | ||||||||
Initial consolidation of a Consolidated Entity | — | — | — | — | — | ||||||||
Contributions | — | — | — | — | — | ||||||||
Dividends and distributions | — | — | — | ( | — | ( | ( | ||||||
Net income | — | — | — | — | |||||||||
Currency translation adjustments | — | — | — | — | |||||||||
Defined benefit plans, net | — | — | — | — | — | ||||||||
Balance at December 31, 2025 | $ | $ | $ | $( | $ | $ |
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
Cash flows from operating activities | |||||
Net income (loss) | $ | $ | $( | ||
Adjustments to reconcile net income (loss) to net cash flows from operating activities: | |||||
Depreciation and amortization | |||||
Equity-based compensation | |||||
Non-cash performance allocations and incentive fees, net | ( | ( | |||
Non-cash principal investment (income) loss | ( | ( | ( | ||
Other non-cash amounts | |||||
Consolidated Funds related: | |||||
Realized/unrealized (gain) loss on investments of Consolidated Funds | ( | ( | ( | ||
Realized/unrealized (gain) loss from loans payable of Consolidated Funds | ( | ||||
Purchases of investments by Consolidated Funds | ( | ( | ( | ||
Proceeds from sales and settlements of investments by Consolidated Funds | |||||
Non-cash interest income, net | ( | ( | ( | ||
Change in cash and cash equivalents held at Consolidated Funds | ( | ( | |||
Change in other receivables held at Consolidated Funds | ( | ( | |||
Change in other liabilities held at Consolidated Funds | |||||
Purchases of investments | ( | ( | ( | ||
Proceeds from the sale of investments | |||||
Payments of contingent consideration | ( | ( | ( | ||
Changes in deferred taxes, net | ( | ( | |||
Change in due from affiliates and other receivables | ( | ( | |||
Change in deposits and other | ( | ||||
Change in accounts payable, accrued expenses and other liabilities | ( | ||||
Change in accrued compensation and benefits | ( | ||||
Change in due to affiliates | ( | ( | |||
Change in lease right-of-use assets and lease liabilities | ( | ( | ( | ||
Change in deferred revenue | ( | ( | |||
Net cash provided by (used in) operating activities | ( | ( | |||
Cash flows from investing activities | |||||
Purchases of corporate treasury investments | ( | ( | |||
Proceeds from corporate treasury investments | |||||
Purchases of fixed assets, net | ( | ( | ( | ||
Net cash used in investing activities | ( | ( | ( | ||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
Cash flows from financing activities | |||||
Borrowings under credit facilities | |||||
Repayments under credit facilities | ( | ||||
Issuance of | |||||
Proceeds from CLO borrowings, net of financing costs | |||||
Payments on CLO borrowings | ( | ( | ( | ||
Net borrowings on loans payable of Consolidated Funds | |||||
Dividends to common stockholders | ( | ( | ( | ||
Payment of deferred consideration for Carlyle Holdings units | ( | ( | |||
Contributions from non-controlling interest holders | |||||
Distributions to non-controlling interest holders | ( | ( | ( | ||
Common shares repurchased and net share settlement of equity awards | ( | ( | ( | ||
Change in due to/from affiliates financing activities | ( | ( | ( | ||
Net cash provided by (used in) financing activities | ( | ||||
Effect of foreign exchange rate changes | ( | ||||
Increase (decrease) in cash, cash equivalents and restricted cash | ( | ||||
Cash, cash equivalents and restricted cash, beginning of period | |||||
Cash, cash equivalents and restricted cash, end of period | $ | $ | $ | ||
Supplemental cash disclosures | |||||
Cash paid for interest | $ | $ | $ | ||
Cash paid for income taxes | $ | $ | $ | ||
Supplemental non-cash disclosures | |||||
Initial consolidation of Consolidated Funds | $ | $ | $ | ||
Net asset impact of deconsolidation of Consolidated Funds | $( | $( | $( | ||
Reconciliation of cash, cash equivalents and restricted cash, end of period: | |||||
Cash and cash equivalents | $ | $ | $ | ||
Restricted cash | |||||
Total cash, cash equivalents and restricted cash, end of period | $ | $ | $ | ||
Cash and cash equivalents held at Consolidated Funds | $ | $ | $ | ||
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Investments | $ | $ | |
Accrued performance allocations | |||
Management fee receivables | |||
Total | $ | $ | |
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Currency translation adjustments | $( | $( | |
Unrealized losses on defined benefit plans | ( | ||
Total | $( | $( | |
(Dollars in millions) | Level I | Level II | Level III | Total | |||
Assets | |||||||
Investments of Consolidated Funds(1): | |||||||
Equity securities(2) | $ | $ | $ | $ | |||
Bonds | |||||||
Loans | |||||||
Investments in CLOs and other: | |||||||
Investments in CLOs | |||||||
Other investments(3) | |||||||
Foreign currency forward contracts | |||||||
Subtotal | $ | $ | $ | $ | |||
Investments measured at net asset value | |||||||
Total | $ | ||||||
Liabilities | |||||||
Loans payable of Consolidated Funds(4)(5) | $ | $ | $ | $ | |||
Foreign currency forward contracts | |||||||
Total | $ | $ | $ | $ | |||
(Dollars in millions) | Level I | Level II | Level III | Total | |||
Assets | (Dollars in millions) | ||||||
Investments of Consolidated Funds(1): | |||||||
Equity securities(2) | $ | $ | $ | $ | |||
Bonds | |||||||
Loans | |||||||
Other | |||||||
Investments in CLOs and other: | |||||||
Investments in CLOs | |||||||
Other investments(3) | |||||||
Subtotal | $ | $ | $ | $ | |||
Investments measured at net asset value | |||||||
Total | $ | ||||||
Liabilities | |||||||
Loans payable of Consolidated Funds(4)(5) | $ | $ | $ | $ | |||
Foreign currency forward contracts | |||||||
Total | $ | $ | $ | $ | |||
Financial Assets Year Ended December 31, 2025 | |||||||||||
Investments of Consolidated Funds | Investments in CLOs | Total | |||||||||
Equity securities | Bonds | Loans | Other investments | ||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | |||||
Initial consolidation/deconsolidation of funds(1) | ( | ( | ( | ||||||||
Transfer out related to the Exchange(2) | ( | ( | |||||||||
Purchases | |||||||||||
Sales and distributions | ( | ( | ( | ( | ( | ( | |||||
Settlements | ( | ( | ( | ||||||||
Realized and unrealized gains (losses), net | |||||||||||
Included in earnings | ( | ( | ( | ||||||||
Included in other comprehensive income | |||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | |||||
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date | $( | $ | $( | $ | $ | $( | |||||
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date | $ | $ | $ | $ | $ | $ | |||||
Financial Assets Year Ended December 31, 2024 | |||||||||||
Investments of Consolidated Funds | Investments in CLOs | Total | |||||||||
Equity securities | Bonds | Loans | Other investments | ||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | |||||
Deconsolidation of funds(3) | ( | ( | ( | ||||||||
Purchases | |||||||||||
Sales and distributions | ( | ( | ( | ( | ( | ( | |||||
Settlements | ( | ( | ( | ||||||||
Realized and unrealized gains (losses), net | |||||||||||
Included in earnings | ( | ||||||||||
Included in other comprehensive income | ( | ( | ( | ( | |||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | |||||
Changes in unrealized gains (losses) included in earnings related to financial assets still held at the reporting date | $ | $ | $ | $ | $( | $ | |||||
Changes in unrealized gains (losses) included in other comprehensive income related to financial assets still held at the reporting date | $ | $( | $( | $( | $ | $( | |||||
Financial Liabilities | |||
Loans Payable of Consolidated Funds | |||
Year Ended December 31, | |||
2025 | 2024 | ||
Balance, beginning of period | $ | $ | |
Initial consolidation/deconsolidation of funds(1) | ( | ( | |
Borrowings | |||
Paydowns | ( | ( | |
Sales | ( | ( | |
Realized and unrealized (gains) losses, net | |||
Included in earnings | ( | ||
Included in other comprehensive income | ( | ||
Balance, end of period | $ | $ | |
Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date | $( | $ | |
Changes in unrealized (gains) losses included in other comprehensive income related to financial liabilities still held at the reporting date | $ | $( | |
Fair Value at | Range (Weighted Average) | Impact to Valuation from Increase in Input | |||||||
(Dollars in millions) | December 31, 2025 | Valuation Technique(s) | Unobservable Input(s) | ||||||
Assets | |||||||||
Investments of Consolidated Funds: | |||||||||
Equity securities | $ | Consensus Pricing | Indicative Quotes ($ per share) | Higher | |||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Terminal Growth Rate | Higher | ||||||||
Comparable Multiple | EBITDA Multiple | Higher | |||||||
Revenue Multiple | Higher | ||||||||
TCF Multiple | Higher | ||||||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Constant Prepayment Rate | Lower | ||||||||
Constant Default Rate | Lower | ||||||||
Recovery Rate | Higher | ||||||||
Other(1) | N/A | N/A | N/A | ||||||
Bonds | Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Loans | Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Constant Prepayment Rate | Lower | ||||||||
Constant Default Rate | Lower | ||||||||
Other(1) | N/A | N/A | N/A | ||||||
Investments in CLOs | |||||||||
Senior secured notes | Consensus Pricing with Discounted Cash Flow | Indicative Quotes (% of Par) | Higher | ||||||
Discount Margins (Basis Points) | Lower | ||||||||
Default Rates | Lower | ||||||||
Recovery Rates | Higher | ||||||||
Subordinated notes and preferred shares | Consensus Pricing with Discounted Cash Flow | Indicative Quotes (% of Par) | Higher | ||||||
Discount Rates | Lower | ||||||||
Default Rates | Lower | ||||||||
Recovery Rates | Higher | ||||||||
Other investments: | |||||||||
Aviation subordinated notes | Discounted Cash Flow | Discount Rates | Lower | ||||||
Loans | Discounted Cash Flow | Discount Rates | Lower | ||||||
Consensus Pricing | Indicative Quotes (% of Par) | Higher | |||||||
Other(1) | N/A | N/A | N/A | ||||||
Total | $ | ||||||||
Liabilities | |||||||||
Loans payable of Consolidated Funds: | |||||||||
Senior secured notes | $ | Other(2) | N/A | N/A | N/A | ||||
Subordinated notes and preferred shares | Consensus Pricing with Discounted Cash Flow | Indicative Quotes (% of Par) | Higher | ||||||
Discount Rates | Lower | ||||||||
Default Rates | Lower | ||||||||
Recovery Rates | Higher | ||||||||
Total | $ |
Fair Value at | Range (Weighted Average) | Impact to Valuation from Increase in Input | |||||||
(Dollars in millions) | December 31, 2024 | Valuation Technique(s) | Unobservable Input(s) | ||||||
Assets | |||||||||
Investments of Consolidated Funds: | |||||||||
Equity securities | $ | Consensus Pricing | Indicative Quotes ($ per share) | Higher | |||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Terminal Growth Rate | Higher | ||||||||
Comparable Multiple | EBITDA Multiple | Higher | |||||||
TCF Multiple | Higher | ||||||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Constant Prepayment Rate | Lower | ||||||||
Constant Default Rate | Lower | ||||||||
Recovery Rate | Higher | ||||||||
Other(1) | N/A | N/A | N/A | ||||||
Bonds | Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Loans | Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Discounted Cash Flow | Discount Rates | Lower | |||||||
Constant Prepayment Rate | Lower | ||||||||
Constant Default Rate | Lower | ||||||||
Recovery Rate | Higher | ||||||||
Other | Other(1) | N/A | N/A | N/A | |||||
Investments in CLOs | |||||||||
Senior secured notes | Discounted Cash Flow with Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Discount Margins (Basis Points) | Lower | ||||||||
Default Rates | Lower | ||||||||
Recovery Rates | Higher | ||||||||
Subordinated notes and preferred shares | Discounted Cash Flow with Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Discount Rate | Lower | ||||||||
Default Rates | Lower | ||||||||
Recovery Rates | Higher | ||||||||
Other investments: | |||||||||
BDC preferred shares | Other(2) | Net Asset Value per Share | Lower | ||||||
Aviation subordinated notes | Discounted Cash Flow | Discount Rates | Lower | ||||||
Loans | Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Total | $ | ||||||||
Liabilities | |||||||||
Loans payable of Consolidated Funds: | |||||||||
Senior secured notes | $ | Other(3) | N/A | N/A | N/A | ||||
Subordinated notes and preferred shares | Discounted Cash Flow with Consensus Pricing | Indicative Quotes (% of Par) | Higher | ||||||
Discount Rates | Lower | ||||||||
Default Rates | Lower | ||||||||
Recovery Rates | Higher | ||||||||
Total | $ |
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Accrued performance allocations | $ | $ | |
Principal equity method investments, excluding performance allocations | |||
Principal investments in CLOs | |||
Other investments | |||
Total | $ | $ | |
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Global Private Equity | $ | $ | |
Global Credit | |||
Carlyle AlpInvest | |||
Total | $ | $ | |
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Global Private Equity | $( | $( | |
Global Credit | ( | ( | |
Total | $( | $( | |
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Global Private Equity(1) | $ | $ | |
Global Credit(2) | |||
Carlyle AlpInvest | |||
Total | $ | $ | |
Global Private Equity | Global Credit | Carlyle AlpInvest | Aggregate Totals | ||||||||||||||||||||
For the Year Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, | ||||||||||||||||||||
2025 | 2024 | 2023 | 2025 | 2024 | 2023 | 2025 | 2024 | 2023 | 2025 | 2024 | 2023 | ||||||||||||
Statement of operations information | |||||||||||||||||||||||
Investment income | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Expenses | |||||||||||||||||||||||
Net investment income (loss) | ( | ( | ( | ( | ( | ( | |||||||||||||||||
Net realized and unrealized gain (loss) | |||||||||||||||||||||||
Net income (loss) | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||
Global Private Equity | Global Credit | Carlyle AlpInvest | Aggregate Totals | ||||||||||||
As of December 31, | As of December 31, | As of December 31, | As of December 31, | ||||||||||||
2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | ||||||||
Balance sheet information | |||||||||||||||
Investments | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Total assets | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Debt | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Other liabilities | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Total liabilities | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
Partners’ capital | $ | $ | $ | $ | $ | $ | $ | $ | |||||||
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Investment in NGP Management | $ | $ | |
Investments in NGP general partners - accrued performance allocations | |||
Principal investments in NGP funds | |||
Total investments in NGP | $ | $ | |
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Management fee related revenues from NGP Management | $ | $ | $ | ||
Expenses related to the investment in NGP Management | ( | ( | ( | ||
Amortization of basis differences and impairment of investment in NGP Management | ( | ||||
Net investment income from NGP Management | $( | $ | $ | ||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Performance allocations | |||||
Realized | $ | $ | $ | ||
Unrealized | ( | ||||
( | |||||
Principal investment income (loss) from equity method investments (excluding performance allocations) | |||||
Realized | |||||
Unrealized | ( | ( | |||
Principal investment income (loss) from investments in CLOs and other investments | |||||
Realized | ( | ( | |||
Unrealized(1) | ( | ( | |||
( | |||||
Total | $ | $ | $ | ||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Global Private Equity | $ | $ | $( | ||
Global Credit | |||||
Carlyle AlpInvest | |||||
Total | $ | $ | $( | ||
Year Ended December 31, 2025 | ||
(Dollars in millions) | ||
Global Private Equity | CP VII | $ |
Global Private Equity | CP VIII | |
Global Private Equity | CAP V | ( |
Year Ended December 31, 2024 | ||
(Dollars in millions) | ||
Global Private Equity | CP VII | $ |
Year Ended December 31, 2023 | ||
(Dollars in millions) | ||
Global Private Equity | CP VI | $( |
Global Private Equity | CP VII | ( |
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Global Private Equity | $ | $ | $ | ||
Global Credit | ( | ||||
Carlyle AlpInvest | |||||
Total | $ | $ | $ | ||
Fair Value | Percentage of Investments of Consolidated Funds | ||||||
Geographic Region/Instrument Type / Industry | As of December 31, | As of December 31, | |||||
Description or Investment Strategy | 2025 | 2024 | 2025 | 2024 | |||
(Dollars in millions) | |||||||
United States | |||||||
Equity securities: | |||||||
Aerospace, Defense & Government Services | $ | $ | |||||
Consumer & Retail | |||||||
Financial Services | |||||||
Healthcare Equipment & Services | |||||||
Industrial | |||||||
Infrastructure | |||||||
Technology & Business Services | |||||||
Telecom & Media | |||||||
Transportation | |||||||
Other | |||||||
Total equity securities (cost of $ 2025 and 2024, respectively) | |||||||
Partnership and LLC interests: | |||||||
Fund Investments | $ | $ | |||||
Total Partnership and LLC interests (cost of $ December 31, 2025 and 2024, respectively) | |||||||
Loans: | |||||||
Aerospace & Defense | $ | $ | |||||
Collateralized Debt Obligation | |||||||
Education | |||||||
Environmental Industries | |||||||
Total loans (cost of $ respectively) | |||||||
Assets of the CLOs: | |||||||
Bonds | $ | $ | |||||
Equity | |||||||
Loans | |||||||
Total assets of the CLOs (cost of $ December 31, 2025 and 2024, respectively) | |||||||
Total United States | $ | $ | |||||
Fair Value | Percentage of Investments of Consolidated Funds | ||||||
Geographic Region/Instrument Type / Industry | As of December 31, | As of December 31, | |||||
Description or Investment Strategy | 2025 | 2024 | 2025 | 2024 | |||
(Dollars in millions) | |||||||
Europe | |||||||
Equity securities: | |||||||
Energy | $ | $ | |||||
Healthcare Equipment & Services | |||||||
Industrial | |||||||
Software | |||||||
Technology & Business Services | |||||||
Other | |||||||
Total equity securities (cost of $ and 2024, respectively) | |||||||
Assets of the CLOs: | |||||||
Bonds | $ | $ | |||||
Equity | |||||||
Loans | |||||||
Other | |||||||
Total assets of the CLOs (cost of $ December 31, 2025 and 2024, respectively) | |||||||
Total Europe | $ | $ | |||||
Global | |||||||
Equity securities: | |||||||
Consumer & Retail | $ | $ | |||||
Hardware | |||||||
Healthcare Equipment & Services | |||||||
Industrial | |||||||
Technology & Business Services | |||||||
Total equity securities (cost of $ and 2024, respectively) | |||||||
Assets of the CLOs: | |||||||
Bonds | $ | $ | |||||
Loans | |||||||
Total assets of the CLOs (cost of $ December 31, 2025 and 2024, respectively) | |||||||
Total Global | $ | $ | |||||
Total investments of Consolidated Funds (cost of $ at December 31, 2025 and 2024, respectively) | $ | $ | |||||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Interest income from investments | $ | $ | $ | ||
Other income | |||||
Total | $ | $ | $ | ||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Gains from investments of Consolidated Funds | $ | $ | $ | ||
Gains (losses) from liabilities of CLOs | ( | ( | |||
Total | $ | $ | $ | ||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Realized gains (losses) | $ | $( | $( | ||
Net change in unrealized gains (losses) | ( | ||||
Total | $ | $ | $ | ||
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Acquired contractual rights | $ | $ | |
Accumulated amortization | ( | ( | |
Finite-lived intangible assets, net | |||
Goodwill | |||
Intangible assets, net | $ | $ | |
Year ending December 31, | |
2026 | $ |
2027 | |
2028 | |
2029 | |
2030 | |
$ |
As of December 31, | |||||||
2025 | 2024 | ||||||
Borrowing Outstanding | Carrying Value | Borrowing Outstanding | Carrying Value | ||||
(Dollars in millions) | |||||||
CLO Borrowings (See below) | $ | $ | $ | $ | |||
Total debt obligations | $ | $ | $ | $ | |||
Formation Date | Borrowing Outstanding December 31, 2025 | Borrowing Outstanding December 31, 2024 | Maturity Date(1) | Interest Rate as of December 31, 2025 | ||||||
February 28, 2017 | $ | $ | September 21, 2029 | (2) | ||||||
December 6, 2017 | N/A | N/A | (4) | |||||||
March 15, 2019 | March 15, 2032 | (3) | ||||||||
August 20, 2019 | August 15, 2032 | (3) | ||||||||
September 15, 2020 | April 15, 2033 | (3) | ||||||||
January 8, 2021 | January 15, 2034 | (3) | ||||||||
March 30, 2021 | March 15, 2032 | (3) | ||||||||
April 21, 2021 | April 15, 2033 | (3) | ||||||||
May 21, 2021 | November 17, 2031 | (3) | ||||||||
June 4, 2021 | January 16, 2034 | (3) | ||||||||
June 10, 2021 | November 17, 2031 | (3) | ||||||||
July 15, 2021 | July 15, 2034 | (3) | ||||||||
July 20, 2021 | July 20, 2034 | (3) | ||||||||
August 4, 2021 | August 15, 2032 | (3) | ||||||||
October 27, 2021 | October 15, 2035 | (3) | ||||||||
January 6, 2022 | February 15, 2035 | (3) | ||||||||
February 22, 2022 | November 10, 2035 | (3) | ||||||||
September 5, 2023 | N/A | N/A | (4) | |||||||
April 25, 2024 | N/A | N/A | (4) | |||||||
December 19, 2024 | January 15, 2039 | (3) | ||||||||
March 31, 2025 | April 15, 2038 | (3) | ||||||||
July 10, 2025 | August 15, 2038 | (3) | ||||||||
September 19, 2025 | October 15, 2038 | (3) | ||||||||
October 28, 2025 | October 25, 2038 | (3) | ||||||||
November 7, 2025 | January 16, 2039 | (3) | ||||||||
$ | $ |
Aggregate Principal Amount | Fair Value(1) As of December 31, | Interest Expense | |||||||||
Year Ended December 31, | |||||||||||
2025 | 2024 | 2025 | 2024 | 2023 | |||||||
$ | $ | $ | $ | $ | $ | ||||||
$ | $ | $ | |||||||||
As of December 31, 2025 | |||||||
Borrowing Outstanding | Fair Value | Weighted Average Interest Rate | Weighted Average Remaining Maturity in Years | ||||
Senior secured notes(1) | $ | $ | |||||
Subordinated notes | N/A | (3) | |||||
Revolving credit facilities(2) | |||||||
Total | $ | $ | |||||
As of December 31, 2024 | |||||||
Borrowing Outstanding | Fair Value | Weighted Average Interest Rate | Weighted Average Remaining Maturity in Years | ||||
Senior secured notes | $ | $ | |||||
Subordinated notes | N/A | (3) | |||||
Revolving credit facilities(2) | |||||||
Total | $ | $ | |||||
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Accrued performance allocations and incentive fee related compensation | $ | $ | |
Accrued bonuses | |||
Realized performance allocations and incentive fee related compensation not yet paid | |||
Other | |||
Total | $ | $ | |
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Realized | $ | $ | $ | ||
Unrealized | |||||
Total | $ | $ | $ | ||
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Benefit obligation | $( | $( | |
Fair value of plan assets | |||
Funded status(1) | $ | $( | |
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Operating lease cost | $ | $ | $ | ||
Sublease income | ( | ( | ( | ||
Total operating lease cost | $ | $ | $ | ||
Cash paid for amounts included in the measurement of operating lease liabilities | $ | $ | $ | ||
Weighted-average remaining lease term | |||||
Weighted-average discount rate | |||||
Year ending December 31, | |
2026 | $ |
2027 | |
2028 | |
2029 | |
2030 | |
Thereafter | |
Total lease payments | $ |
Less imputed interest | ( |
Total lease liabilities | $ |
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Accrued incentive fees | $ | $ | |
Unbilled receivable for giveback obligations from current and former employees | |||
Notes receivable and accrued interest from affiliates | |||
Management fee receivable, net | |||
Reimbursable expenses and other receivables from unconsolidated funds and affiliates, net | |||
Total | $ | $ | |
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Due to affiliates of Consolidated Funds | $ | $ | |
Due to non-consolidated affiliates | |||
Amounts owed under the tax receivable agreement | |||
Other | |||
Total | $ | $ | |
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
U.S. domestic income (loss) | $ | $ | $( | ||
Foreign income | |||||
Total income (loss) before provision for income taxes | $ | $ | $( | ||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Current | |||||
Federal income tax | $ | $ | $ | ||
State and local income tax | |||||
Foreign income tax | |||||
Total current | |||||
Deferred | |||||
Federal income tax | ( | ( | |||
State and local income tax | ( | ( | ( | ||
Foreign income tax | ( | ( | ( | ||
Total deferred | ( | ( | |||
Total provision (benefit) for income taxes | $ | $ | $( | ||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Income (loss) before provision for income taxes | $ | $ | $( | ||
Provision (benefit) for income taxes | $ | $ | $( | ||
Effective income tax rate | |||||
Year Ended December 31, | ||||||||
2025 | 2024 | 2023 | ||||||
(Dollars in millions) | ||||||||
Statutory U.S. federal income tax rate | $ | $ | $( | |||||
State and local income taxes, net of federal effect(1) | ( | |||||||
Foreign tax effects | ||||||||
Netherlands | ( | |||||||
United Kingdom | ( | |||||||
Other foreign jurisdictions | ( | |||||||
Effect of cross-border tax laws | ||||||||
Foreign tax credits | ( | ( | ( | ( | ( | |||
Basis difference in investments | ( | ( | ||||||
Other | ( | ( | ( | |||||
Tax credits | ( | ( | ( | ( | ( | |||
Changes in valuation allowances | ||||||||
Nontaxable or nondeductible items | ||||||||
Nontaxable income to non-controlling interest holders | ( | ( | ( | ( | ( | |||
Officer compensation limitation | ( | |||||||
Other nontaxable or nondeductible items | ( | ( | ( | |||||
Changes in unrecognized tax benefits(2) | ( | ( | ( | |||||
Net excess tax benefits on equity-based compensation | ( | ( | ( | ( | ( | |||
Other | ( | ( | ( | |||||
Effective income tax rate | $ | $ | $( | |||||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Federal income tax | $ | $ | $ | ||
State and local income tax | |||||
Foreign income tax | |||||
Netherlands | |||||
United Kingdom | |||||
Other foreign income tax | |||||
Total | $ | $ | $ | ||
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Deferred tax assets | |||
Federal foreign tax credit carryforward | $ | $ | |
State net operating loss carryforwards | |||
Foreign net operating loss carryforwards | |||
Tax basis goodwill and intangibles | |||
Depreciation and amortization | |||
Deferred equity-based compensation | |||
Lease liabilities | |||
Accrued compensation | |||
Other | |||
Deferred tax assets before valuation allowance | |||
Valuation allowance | ( | ( | |
Total deferred tax assets | $ | $ | |
Deferred tax liabilities(1) | |||
Unrealized appreciation on investments | $ | $ | |
Lease right-of-use assets | |||
Basis difference in investments | |||
Other | |||
Total deferred tax liabilities | $ | $ | |
Net deferred tax assets (liabilities) | $( | $( | |
December 31, 2025 | |||
(Dollars in millions) | Expiration Year(1) | ||
Federal foreign tax credit | $ | 2030 | |
State net operating loss | 2026 | ||
Foreign net operating loss | 2037 | ||
As of December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Balance at January 1 | $ | $ | $ | ||
Additions based on tax positions related to current year | |||||
Additions for tax positions of prior years | |||||
Reductions for tax position of prior years | ( | ( | ( | ||
Reductions due to lapse of statute of limitations | ( | ( | ( | ||
Reductions due to settlements | ( | ||||
Balance at December 31 | $ | $ | $ | ||
As of December 31, | |||
2025 | 2024 | ||
(Dollars in millions) | |||
Non-Carlyle interests in Consolidated Funds | $ | $ | |
Non-Carlyle interests in majority-owned subsidiaries | |||
Non-controlling interest in carried interest and giveback obligations | ( | ||
Non-controlling interests in consolidated entities | $ | $ | |
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Non-Carlyle interests in Consolidated Funds | $ | $ | $ | ||
Non-Carlyle interests in majority-owned subsidiaries | |||||
Non-controlling interest in carried interest and giveback obligations | ( | ||||
Non-controlling interests in income of consolidated entities | $ | $ | $ | ||
Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 | |||||||||
Basic | Diluted | Basic | Diluted | Basic | Diluted | ||||||
Net income (loss) attributable to common shares | $ | $ | $ | $ | $( | $( | |||||
Weighted-average common shares outstanding | |||||||||||
Net income (loss) per common share | $ | $ | $ | $ | $( | $( | |||||
Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 | |||||||||
Basic | Diluted | Basic | Diluted | Basic | Diluted | ||||||
The Carlyle Group Inc. weighted-average common shares outstanding | |||||||||||
Unvested restricted stock units | |||||||||||
Issuable common shares and performance- vesting restricted stock units | |||||||||||
Weighted-average common shares outstanding | |||||||||||
Year Ended December 31, | |||||||
2025 | 2024 | ||||||
Shares | $ | Shares | $ | ||||
(Dollars in millions) | |||||||
Shares repurchased | $ | $ | |||||
Shares retired in connection with the net share settlement of equity-based awards | |||||||
Total | $ | $ | |||||
Dividend Record Date | Dividend Payment Date | Dividend per Common Share | Dividend to Common Stockholders | |||
(Dollars in millions, except per share data) | ||||||
May 14, 2024 | May 21, 2024 | $ | $ | |||
August 16, 2024 | August 26, 2024 | |||||
November 18, 2024 | November 25, 2024 | |||||
February 21, 2025 | February 28, 2025 | |||||
Total 2024 Dividend Year | $ | $ | ||||
May 19, 2025 | May 27, 2025 | $ | $ | |||
August 18, 2025 | August 28, 2025 | |||||
November 10, 2025 | November 19, 2025 | |||||
February 16, 2026 | February 20, 2026 | |||||
Total 2025 Dividend Year | $ | $ | ||||
Unvested Shares | Performance- Vesting Restricted Stock Units | Weighted- Average Grant Date Fair Value | Restricted Stock Units | Weighted- Average Grant Date Fair Value | Unvested Common Shares | Weighted- Average Grant Date Fair Value | |||||
Balance, December 31, 2022 | $ | $ | $ | ||||||||
Granted(1) | $ | $ | $ | ||||||||
Vested | $ | $ | $ | ||||||||
Forfeited | $ | $ | $ | ||||||||
Balance, December 31, 2023 | $ | $ | $ | ||||||||
Granted(1) | $ | $ | $ | ||||||||
Vested(2) | $ | $ | $ | ||||||||
Forfeited | $ | $ | $ | ||||||||
Balance, December 31, 2024 | $ | $ | $ | ||||||||
Granted(1) | $ | $ | $ | ||||||||
Vested(3) | $ | $ | $ | ||||||||
Forfeited | $ | $ | $ | ||||||||
Balance, December 31, 2025 | $ | $ | $ |
Year Ended December 31, 2025 | |||||||
Global Private Equity | Global Credit | Carlyle AlpInvest | Total | ||||
(Dollars in millions) | |||||||
Segment Revenues | |||||||
Fund level fee revenues | |||||||
Fund management fees | $ | $ | $ | $ | |||
Portfolio advisory and transaction fees, net and other | |||||||
Fee related performance revenues | |||||||
Total fund level fee revenues | |||||||
Realized performance revenues | |||||||
Realized principal investment income | |||||||
Interest income | |||||||
Total revenues | |||||||
Segment Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | |||||||
Realized performance revenues related compensation | |||||||
Total compensation and benefits | |||||||
General, administrative, and other indirect expenses(1) | |||||||
Depreciation and amortization expense | |||||||
Interest expense | |||||||
Total expenses | |||||||
(=) Distributable Earnings | $ | $ | $ | $ | |||
(-) Realized Net Performance Revenues | |||||||
(-) Realized Principal Investment Income | |||||||
(+) Net Interest | |||||||
(=) Fee Related Earnings | $ | $ | $ | $ | |||
Year Ended December 31, 2024 | |||||||
Global Private Equity | Global Credit | Carlyle AlpInvest | Total | ||||
(Dollars in millions) | |||||||
Segment Revenues | |||||||
Fund level fee revenues | |||||||
Fund management fees | $ | $ | $ | $ | |||
Portfolio advisory and transaction fees, net and other | |||||||
Fee related performance revenues | |||||||
Total fund level fee revenues | |||||||
Realized performance revenues | |||||||
Realized principal investment income | |||||||
Interest income | |||||||
Total revenues | |||||||
Segment Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | |||||||
Realized performance revenues related compensation | |||||||
Total compensation and benefits | |||||||
General, administrative, and other indirect expenses(1) | |||||||
Depreciation and amortization expense | |||||||
Interest expense | |||||||
Total expenses | |||||||
(=) Distributable Earnings | $ | $ | $ | $ | |||
(-) Realized Net Performance Revenues | |||||||
(-) Realized Principal Investment Income | |||||||
(+) Net Interest | |||||||
(=) Fee Related Earnings | $ | $ | $ | $ | |||
Year Ended December 31, 2023 | |||||||
Global Private Equity | Global Credit | Carlyle AlpInvest | Total | ||||
(Dollars in millions) | |||||||
Segment Revenues | |||||||
Fund level fee revenues | |||||||
Fund management fees | $ | $ | $ | $ | |||
Portfolio advisory and transaction fees, net and other | |||||||
Fee related performance revenues | |||||||
Total fund level fee revenues | |||||||
Realized performance revenues | |||||||
Realized principal investment income | |||||||
Interest income | |||||||
Total revenues | |||||||
Segment Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | |||||||
Realized performance revenues related compensation | |||||||
Total compensation and benefits | |||||||
General, administrative, and other indirect expenses(1) | |||||||
Depreciation and amortization expense | |||||||
Interest expense | |||||||
Total expenses | |||||||
(=) Distributable Earnings | $ | $ | $ | $ | |||
(-) Realized Net Performance Revenues | |||||||
(-) Realized Principal Investment Income | |||||||
(+) Net Interest | |||||||
(=) Fee Related Earnings | $ | $ | $ | $ | |||
Year Ended December 31, 2025 | |||||||||
Total Reportable Segments | Consolidated Funds | Reconciling Items | Carlyle Consolidated | ||||||
(Dollars in millions) | |||||||||
Revenues | $ | $ | $ | (a) | $ | ||||
Expenses | $ | $ | $ | (b) | $ | ||||
Other income (loss) | $ | $ | $ | (c) | $ | ||||
Distributable earnings | $ | $ | $( | (d) | $ | ||||
Year Ended December 31, 2024 | |||||||||
Total Reportable Segments | Consolidated Funds | Reconciling Items | Carlyle Consolidated | ||||||
(Dollars in millions) | |||||||||
Revenues | $ | $ | $ | (a) | $ | ||||
Expenses | $ | $ | $ | (b) | $ | ||||
Other income (loss) | $ | $ | $ | (c) | $ | ||||
Distributable earnings | $ | $ | $( | (d) | $ | ||||
Year Ended December 31, 2023 | |||||||||
Total Reportable Segments | Consolidated Funds | Reconciling Items | Carlyle Consolidated | ||||||
(Dollars in millions) | |||||||||
Revenues | $ | $ | $( | (a) | $ | ||||
Expenses | $ | $ | $ | (b) | $ | ||||
Other income (loss) | $ | $ | $ | (c) | $ | ||||
Distributable earnings | $ | $ | $( | (d) | $( | ||||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Unrealized performance and fee related performance revenues | $ | $ | $( | ||
Unrealized principal investment income (loss) | ( | ||||
Principal investment loss from dilution of indirect investment in Fortitude | ( | ||||
Adjustments related to expenses associated with investments in NGP Management and its affiliates | ( | ( | ( | ||
Non-controlling interests and other adjustments to present certain costs on a net basis | |||||
Elimination of revenues of Consolidated Funds | ( | ( | ( | ||
$ | $ | $( | |||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Total Reportable Segments - Fund level fee revenues | $ | $ | $ | ||
Adjustments(1) | ( | ( | ( | ||
Carlyle Consolidated - Fund management fees | $ | $ | $ | ||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Unrealized performance and fee related performance revenue compensation expense | $ | $ | $ | ||
Equity-based compensation | |||||
Acquisition or disposition-related charges and amortization of intangibles and impairment | |||||
Tax (expense) benefit associated with certain foreign performance revenues related compensation | ( | ( | ( | ||
Non-controlling interests and other adjustments to present certain costs on a net basis | |||||
Other adjustments | |||||
Elimination of expenses of Consolidated Funds | ( | ( | ( | ||
$ | $ | $ | |||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Income (loss) before provision for income taxes | $ | $ | $( | ||
Adjustments: | |||||
Net unrealized performance and fee related performance revenues | ( | ( | |||
Unrealized principal investment (income) loss | ( | ( | |||
Principal investment loss from dilution of indirect investment in Fortitude | |||||
Equity-based compensation(1) | |||||
Acquisition or disposition-related charges, including amortization of intangibles and impairment | |||||
Net income attributable to non-controlling interests in consolidated entities | ( | ( | ( | ||
Tax (expense) benefit associated with certain foreign performance revenues | ( | ( | ( | ||
Other adjustments(2) | |||||
Distributable Earnings | $ | $ | $ | ||
Realized performance revenues, net of related compensation(3) | |||||
Realized principal investment income(3) | |||||
Net interest | |||||
Fee Related Earnings | $ | $ | $ | ||
Year Ended December 31, 2025 | |||||
Carlyle Consolidated | Adjustments(4) | Total Reportable Segments | |||
(Dollars in millions) | |||||
Performance revenues | $ | $( | $ | ||
Performance revenues related compensation expense | ( | ||||
Net performance revenues | $ | $ | $ | ||
Principal investment income (loss) | $ | $ | $ | ||
Year Ended December 31, 2024 | |||||
Carlyle Consolidated | Adjustments(4) | Total Reportable Segments | |||
(Dollars in millions) | |||||
Performance revenues | $ | $( | $ | ||
Performance revenues related compensation expense | ( | ||||
Net performance revenues | $ | $( | $ | ||
Principal investment income (loss) | $ | $( | $ | ||
Year Ended December 31, 2023 | |||||
Carlyle Consolidated | Adjustments(4) | Total Reportable Segments | |||
(Dollars in millions) | |||||
Performance revenues | $( | $ | $ | ||
Performance revenues related compensation expense | ( | ||||
Net performance revenues | $( | $ | $ | ||
Principal investment income (loss) | $ | $( | $ | ||
Total Revenues | |||
Share | % | ||
(Dollars in millions) | |||
Year Ended December 31, 2025 | |||
Americas(1) | $ | ||
EMEA(2) | |||
Asia-Pacific(3) | |||
Total | $ | ||
Total Revenues | |||
Share | % | ||
(Dollars in millions) | |||
Year Ended December 31, 2024 | |||
Americas(1) | $ | ||
EMEA(2) | |||
Asia-Pacific(3) | |||
Total | $ | ||
Total Revenues | |||
Share | % | ||
(Dollars in millions) | |||
Year Ended December 31, 2023 | |||
Americas(1) | $ | ||
EMEA(2) | |||
Asia-Pacific(3) | |||
Total | $ | ||
As of December 31, 2025 | |||||||
Consolidated Operating Entities | Consolidated Funds | Eliminations | Consolidated | ||||
(Dollars in millions) | |||||||
Assets | |||||||
Cash and cash equivalents | $ | $ | $ | $ | |||
Cash and cash equivalents held at Consolidated Funds | |||||||
Investments, including accrued performance allocations of $ | ( | ||||||
Investments of Consolidated Funds | |||||||
Due from affiliates and other receivables, net | ( | ||||||
Due from affiliates and other receivables of Consolidated Funds, net | |||||||
Fixed assets, net | |||||||
Lease right-of-use assets, net | |||||||
Deposits and other | |||||||
Intangible assets, net | |||||||
Deferred tax assets | |||||||
Total assets | $ | $ | $( | $ | |||
Liabilities and equity | |||||||
Debt obligations | $ | $ | $ | $ | |||
Loans payable of Consolidated Funds | ( | ||||||
Accounts payable, accrued expenses and other liabilities | |||||||
Accrued compensation and benefits | |||||||
Due to affiliates | |||||||
Deferred revenue | |||||||
Deferred tax liabilities | |||||||
Other liabilities of Consolidated Funds | ( | ||||||
Lease liabilities | |||||||
Accrued giveback obligations | |||||||
Total liabilities | ( | ||||||
Common stock | |||||||
Additional paid-in capital | ( | ||||||
Retained earnings | |||||||
Accumulated other comprehensive loss | ( | ( | |||||
Non-controlling interests in consolidated entities | |||||||
Total equity | ( | ||||||
Total liabilities and equity | $ | $ | $( | $ | |||
As of December 31, 2024 | |||||||
Consolidated Operating Entities | Consolidated Funds | Eliminations | Consolidated | ||||
(Dollars in millions) | |||||||
Assets | |||||||
Cash and cash equivalents | $ | $ | $ | $ | |||
Cash and cash equivalents held at Consolidated Funds | |||||||
Investments, including accrued performance allocations of $ | ( | ||||||
Investments of Consolidated Funds | |||||||
Due from affiliates and other receivables, net | ( | ||||||
Due from affiliates and other receivables of Consolidated Funds, net | |||||||
Fixed assets, net | |||||||
Lease right-of-use assets, net | |||||||
Deposits and other | |||||||
Intangible assets, net | |||||||
Deferred tax assets | |||||||
Total assets | $ | $ | $( | $ | |||
Liabilities and equity | |||||||
Debt obligations | $ | $ | $ | $ | |||
Loans payable of Consolidated Funds | ( | ||||||
Accounts payable, accrued expenses and other liabilities | |||||||
Accrued compensation and benefits | |||||||
Due to affiliates | |||||||
Deferred revenue | |||||||
Deferred tax liabilities | |||||||
Other liabilities of Consolidated Funds | ( | ||||||
Lease liabilities | |||||||
Accrued giveback obligations | |||||||
Total liabilities | ( | ||||||
Common stock | |||||||
Additional paid-in capital | ( | ||||||
Retained earnings | |||||||
Accumulated other comprehensive loss | ( | ( | ( | ||||
Non-controlling interests in consolidated entities | |||||||
Total equity | ( | ||||||
Total liabilities and equity | $ | $ | $( | $ | |||
Year Ended December 31, 2025 | |||||||
Consolidated Operating Entities | Consolidated Funds | Eliminations | Consolidated | ||||
(Dollars in millions) | |||||||
Revenues | |||||||
Fund management fees | $ | $ | $( | $ | |||
Incentive fees | ( | ||||||
Investment income | |||||||
Performance allocations | ( | ||||||
Principal investment income | |||||||
Total investment income | |||||||
Interest and other income | ( | ||||||
Interest and other income of Consolidated Funds | |||||||
Total revenues | ( | ||||||
Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | |||||||
Equity-based compensation | |||||||
Performance allocations and incentive fee related compensation | |||||||
Total compensation and benefits | |||||||
General, administrative and other expenses | ( | ||||||
Interest | |||||||
Interest and other expenses of Consolidated Funds | ( | ||||||
Other non-operating income | ( | ( | |||||
Total expenses | ( | ||||||
Other income | |||||||
Net investment income of Consolidated Funds | |||||||
Income before provision for income taxes | |||||||
Provision for income taxes | |||||||
Net income | |||||||
Net income attributable to non-controlling interests in consolidated entities | |||||||
Net income attributable to The Carlyle Group Inc. | $ | $ | $( | $ | |||
Year Ended December 31, 2024 | |||||||
Consolidated Operating Entities | Consolidated Funds | Eliminations | Consolidated | ||||
(Dollars in millions) | |||||||
Revenues | |||||||
Fund management fees | $ | $ | $( | $ | |||
Incentive fees | ( | ||||||
Investment income | |||||||
Performance allocations | ( | ||||||
Principal investment income | ( | ||||||
Total investment income | ( | ||||||
Interest and other income | ( | ||||||
Interest and other income of Consolidated Funds | |||||||
Total revenues | ( | ||||||
Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | |||||||
Equity-based compensation | |||||||
Performance allocations and incentive fee related compensation | |||||||
Total compensation and benefits | |||||||
General, administrative and other expenses | |||||||
Interest | |||||||
Interest and other expenses of Consolidated Funds | ( | ||||||
Other non-operating income | ( | ( | |||||
Total expenses | ( | ||||||
Other income | |||||||
Net investment income of Consolidated Funds | |||||||
Income before provision for income taxes | ( | ||||||
Provision for income taxes | |||||||
Net income | ( | ||||||
Net income attributable to non-controlling interests in consolidated entities | |||||||
Net income attributable to The Carlyle Group Inc. | $ | $ | $( | $ | |||
Year Ended December 31, 2023 | |||||||
Consolidated Operating Entities | Consolidated Funds | Eliminations | Consolidated | ||||
(Dollars in millions) | |||||||
Revenues | |||||||
Fund management fees | $ | $ | $( | $ | |||
Incentive fees | ( | ||||||
Investment income | |||||||
Performance allocations | ( | ( | ( | ||||
Principal investment income | ( | ||||||
Total investment income | ( | ||||||
Interest and other income | ( | ||||||
Interest and other income of Consolidated Funds | |||||||
Total revenues | ( | ||||||
Expenses | |||||||
Compensation and benefits | |||||||
Cash-based compensation and benefits | |||||||
Equity-based compensation | |||||||
Performance allocations and incentive fee related compensation | |||||||
Total compensation and benefits | |||||||
General, administrative and other expenses | |||||||
Interest | |||||||
Interest and other expenses of Consolidated Funds | ( | ||||||
Other non-operating expenses | |||||||
Total expenses | ( | ||||||
Other income | |||||||
Net investment income of Consolidated Funds | |||||||
Income (loss) before provision for income taxes | ( | ( | ( | ||||
Benefit for income taxes | ( | ( | |||||
Net income (loss) | ( | ( | ( | ||||
Net income attributable to non-controlling interests in consolidated entities | |||||||
Net income (loss) attributable to The Carlyle Group Inc. | $( | $ | $( | $( | |||
Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(Dollars in millions) | |||||
Cash flows from operating activities | |||||
Net income (loss) | $ | $ | $( | ||
Adjustments to reconcile net income (loss) to net cash flows from operating activities: | |||||
Depreciation and amortization | |||||
Equity-based compensation | |||||
Non-cash performance allocations and incentive fees | ( | ( | |||
Non-cash principal investment income | ( | ( | ( | ||
Other non-cash amounts | |||||
Purchases of investments | ( | ( | ( | ||
Proceeds from the sale of investments | |||||
Payments of contingent consideration | ( | ( | ( | ||
Change in deferred taxes, net | ( | ( | |||
Change in due from affiliates and other receivables | ( | ( | |||
Change in deposits and other | ( | ||||
Change in accounts payable, accrued expenses and other liabilities | ( | ||||
Change in accrued compensation and benefits | ( | ||||
Change in due to affiliates | ( | ( | |||
Change in lease right-of-use assets and lease liabilities | ( | ( | ( | ||
Change in deferred revenue | ( | ( | |||
Net cash provided by operating activities | |||||
Cash flows from investing activities | |||||
Purchases of corporate treasury investments | ( | ( | |||
Proceeds from corporate treasury investments | |||||
Purchases of fixed assets, net | ( | ( | ( | ||
Net cash used in investing activities | ( | ( | ( | ||
Cash flows from financing activities | |||||
Borrowings under credit facilities | |||||
Repayments under credit facilities | ( | ||||
Issuance of | |||||
Payments on CLO borrowings | ( | ( | ( | ||
Proceeds from CLO borrowings, net of financing costs | |||||
Dividends to common stockholders | ( | ( | ( | ||
Payment of deferred consideration for Carlyle Holdings units | ( | ( | |||
Contributions from non-controlling interest holders | |||||
Distributions to non-controlling interest holders | ( | ( | ( | ||
Common shares repurchased and net share settlement of equity-based awards | ( | ( | ( | ||
Change in due to/from affiliates financing activities | ( | ( | ( | ||
Net cash used in financing activities | ( | ( | ( | ||
Effect of foreign exchange rate changes | ( | ||||
Increase (decrease) in cash, cash equivalents and restricted cash | ( | ||||
Cash, cash equivalents and restricted cash, beginning of period | |||||
Cash, cash equivalents and restricted cash, end of period | $ | $ | $ | ||
Reconciliation of cash, cash equivalents and restricted cash, end of period: | |||||
Cash and cash equivalents | $ | $ | $ | ||
Restricted cash | |||||
Total cash, cash equivalents and restricted cash, end of period | $ | $ | $ | ||
Cash and cash equivalents held at Consolidated Funds | $ | $ | $ | ||
Report of Independent Registered Public Accounting Firm (PCAOB ID: | 148 |
Consolidated Balance Sheets as of December 31, 2025 and 2024 | 151 |
Consolidated Statements of Operations for the Years Ended December 31, 2025, 2024 and 2023 | 152 |
Consolidated Statements of Comprehensive Income for the Years Ended December 31, 2025, 2024 and 2023 | 153 |
Consolidated Statements of Changes in Equity for the Years Ended December 31, 2025, 2024 and 2023 | 154 |
Consolidated Statements of Cash Flows for the Years Ended December 31, 2025, 2024 and 2023 | 155 |
Notes to Consolidated Financial Statements | 157 |
Exhibit Index | ||
Exhibit Number | Description | |
3.1 | Amended and Restated Certificate of Incorporation of The Carlyle Group Inc. (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on June 2, 2023). | |
3.2 | Bylaws of The Carlyle Group Inc. (incorporated by reference to Exhibit 3.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 2, 2020). | |
4.1 | Indenture dated as of March 28, 2013 among Carlyle Holdings II Finance L.L.C., The Carlyle Group L.P., Carlyle Holdings I L.P., Carlyle Holdings III L.P. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 28, 2013). | |
4.2 | First Supplemental Indenture dated as of March 28, 2013 among Carlyle Holdings II Finance L.L.C., The Carlyle Group L.P., Carlyle Holdings I L.P., Carlyle Holdings II L.P., Carlyle Holdings III L.P. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 28, 2013). | |
4.3 | Form of 5.625% Senior Note due 2043 (included in Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 28, 2013). | |
4.4 | Second Supplemental Indenture dated as of March 10, 2014 among Carlyle Holdings II Finance L.L.C., The Carlyle Group L.P., Carlyle Holdings I L.P., Carlyle Holdings II L.P., Carlyle Holdings III L.P. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on March 10, 2014). | |
4.5 | Third Supplemental Indenture dated as of January 1, 2020 among Carlyle Holdings II Finance L.L.C., The Carlyle Group Inc., Carlyle Holdings I L.P., Carlyle Holdings II L.P., Carlyle Holdings II L.L.C., Carlyle Holdings III L.P., CG Subsidiary Holdings L.L.C. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.9 to the Registrant’s Annual Report on Form 10-K filed with the SEC on February 12, 2020). | |
4.6 | Indenture dated as of September 14, 2018 among Carlyle Finance L.L.C., The Carlyle Group L.P., Carlyle Holdings I L.P., Carlyle Holdings II L.P., Carlyle Holdings III L.P. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 14, 2018). | |
4.7 | First Supplemental Indenture dated as of September 14, 2018 among Carlyle Finance L.L.C., The Carlyle Group L.P., Carlyle Holdings I L.P., Carlyle Holdings II L.P., Carlyle Holdings III L.P. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 14, 2018). | |
4.8 | Form of 5.650% Senior Note due 2048 (included in Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 14, 2018). | |
4.9 | Second Supplemental Indenture dated as of January 1, 2020 among Carlyle Finance L.L.C., The Carlyle Group Inc., Carlyle Holdings I L.P., Carlyle Holdings II L.P., Carlyle Holdings II L.L.C., Carlyle Holdings III L.P., CG Subsidiary Holdings L.L.C. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.12 to the Registrant’s Annual Report on Form 10-K filed with the SEC on February 12, 2020). | |
4.10 | Indenture dated as of September 19, 2019 among Carlyle Finance Subsidiary L.L.C., The Carlyle Group L.P., Carlyle Holdings I L.P., Carlyle Holdings II L.P., Carlyle Holdings III L.P. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 19, 2019). | |
4.11 | First Supplemental Indenture dated as of September 19, 2019 among Carlyle Finance Subsidiary L.L.C., The Carlyle Group L.P., Carlyle Holdings I L.P., Carlyle Holdings II L.P., Carlyle Holdings III L.P. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 19, 2019). | |
4.12 | Form of 3.500% Senior Notes due 2029 (included in Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 19, 2019). | |
4.13 | Second Supplemental Indenture dated as of January 1, 2020 among Carlyle Finance Subsidiary L.L.C., The Carlyle Group Inc., Carlyle Holdings I L.P., Carlyle Holdings II L.P., Carlyle Holdings II L.L.C., Carlyle Holdings III L.P., CG Subsidiary Holdings L.L.C. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.17 to the Registrant’s Annual Report on Form 10-K filed with the SEC on February 12, 2020). | |
4.14 | Subordinated Indenture dated as of May 11, 2021 among Carlyle Finance L.L.C., the Guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 11, 2021). | |
4.15 | First Supplemental Indenture dated as of May 11, 2021 among Carlyle Finance L.L.C., the Guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 11, 2021). | |
4.16 | Form of 4.625% Subordinated Note due 2061 (included in Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 11, 2021). | |
4.17 | Second Supplemental Indenture dated as of June 8, 2021 among Carlyle Finance L.L.C., the Guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on June 8, 2021). | |
4.18 | Base Indenture dated as of September 19, 2025 among The Carlyle Group Inc., the Guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 19, 2025). | |
4.19 | First Supplemental Indenture dated as of September 19, 2025 among The Carlyle Group Inc., the Guarantors named therein and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 19, 2025). | |
4.20 | Form of 5.050% Senior Note due 2035 (included in Exhibit 4.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on September 19, 2025). | |
4.21* | Description of Securities. |
10.1 | Tax Receivable Agreement, dated as of May 2, 2012 by and among The Carlyle Group L.P., Carlyle Holdings I GP Inc., Carlyle Holdings I L.P. and each of the limited partners of the Carlyle Holdings Partnerships party thereto (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 8, 2012). | |
10.2 | Amendment to Tax Receivable Agreement, dated as of January 1, 2020 by and among the Corporation, Carlyle Holdings I GP Inc., Carlyle Holdings I L.P. and each of the limited partners of the Carlyle Holdings Partnerships party thereto (incorporated by reference to Exhibit 99.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 2, 2020). | |
10.3 | Registration Rights Agreement by and among the Partnership, MDC/TCP Investments (Cayman) I, Ltd., MDC/ TCP Investments (Cayman) II, Ltd., MDC/TCP Investments (Cayman) III, Ltd., MDC/TCP Investments (Cayman) IV, Ltd., MDC/TCP Investments (Cayman) V, Ltd., MDC/TCP Investments (Cayman) VI, Ltd. and Five Overseas Investment L.L.C, dated as of May 8, 2012 (incorporated by reference to Exhibit 10.7 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 8, 2012). | |
10.4 | Amended and Restated Registration Rights Agreement with Senior Carlyle Professionals, dated as of January 1, 2020 by and among the Corporation, TCG Carlyle Global Partners L.L.C. and the Covered Persons (defined therein) party thereto (incorporated by reference to Exhibit 99.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 2, 2020). | |
10.5+ | The Carlyle Group Inc. Amended and Restated 2012 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 31, 2024). | |
10.6+ | Stockholder Agreement by and between the Corporation and William E. Conway, Jr., dated as of January 1, 2020 (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 2, 2020). | |
10.7+ | Stockholder Agreement by and between the Corporation and Daniel A. D’Aniello, dated as of January 1, 2020 (incorporated by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 2, 2020). | |
10.8+ | Stockholder Agreement by and between the Corporation and David M. Rubenstein, dated as of January 1, 2020 (incorporated by reference to Exhibit 10.3 to the Registrant’s Current Report on Form 8-K filed with the SEC on January 2, 2020). | |
10.9 | Note and Unit Subscription Agreement, dated as of December 16, 2010 by and among TC Group, L.L.C., TC Group Cayman, L.P., TC Group Investment Holdings, L.P., TC Group Cayman Investment Holdings, L.P., TCG Holdings, L.L.C., TCG Holdings Cayman, L.P., TCG Holdings II, L.P., TCG Holdings Cayman II, L.P., Fortieth Investment Company L.L.C., MDC/TCP Investments (Cayman) I, Ltd., MDC/TCP Investments (Cayman) II, Ltd., MDC/TCP Investments (Cayman) III, Ltd., MDC/TCP Investments (Cayman) IV, Ltd., MDC/TCP Investments (Cayman) V, Ltd., MDC/TCP Investments (Cayman) VI, Ltd., and Five Overseas Investment L.L.C. (incorporated by reference to Exhibit 10.14 to the Registrant’s Registration Statement on Form S-1/A filed with the SEC on February 14, 2012). | |
10.10 | Amended and Restated Office Lease by and between Teachers Insurance and Annuity Association of America and Carlyle Investment Management L.L.C., dated as of June 14, 2019 (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on August 1, 2018). | |
10.11 | Form of Amended and Restated Limited Partnership Agreement of Fund General Partner (Delaware) (incorporated by reference to Exhibit 10.21 to the Registrant’s Registration Statement on Form S-1/A filed with the SEC on February 14, 2012). | |
10.12 | Form of Amended and Restated Limited Partnership Agreement of Fund General Partner (Cayman Islands) (incorporated by reference to Exhibit 10.22 to the Registrant’s Registration Statement on Form S-1/A filed with the SEC on February 14, 2012). | |
10.13† | Third Amended and Restated Credit Agreement, dated as of May 29, 2025, among TC Group Cayman, L.P., Carlyle Investment Management L.L.C., and CG Subsidiary Holdings L.L.C., as Borrowers, TC Group, L.L.C., Carlyle Holdings I L.P., Carlyle Holdings II L.L.C., Carlyle Holdings III L.P. and Carlyle Finance Subsidiary L.L.C. as Parent Guarantors, the Lenders Party Hereto, and Citibank, N.A. as Administrative Agent, and Citibank, N.A., JPMorgan Chase Bank, N.A., BofA Securities, Inc. and Wells Fargo Securities, LLC as Joint Lead Arrangers and Bookrunners, and JPMorgan Chase Bank, N.A., Bank of America, N.A. and Wells Fargo Bank, National Association, as Syndication Agents (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on August 8, 2025). | |
10.14 | Revolving Credit Agreement, dated as of December 17, 2018, as amended by Amendment No. 1 on December 16, 2019, Amendment No. 2 on December 15, 2020, Amendment No. 3 on September 1, 2021, Amendment No. 4 on January 25, 2022, Amendment No. 5 on August 23, 2023, Amendment No. 6 on August 21, 2024, and Amendment No. 7 on August 20, 2025, among TCG Capital Markets L.L.C. and TCG Senior Funding L.L.C., as Borrowers, the Lenders party hereto, and Mizuho Bank, Ltd., as Administrative Agent, and Mizuho Bank, Ltd., as Sole Lead Arranger and Sole Bookrunner (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on November 7, 2025). | |
10.15+ | Form of Indemnification Agreement (incorporated by reference to Exhibit 10.23 to the Registrant’s Annual Report on Form 10-K filed with the SEC on February 12, 2020). | |
10.16+ | Employment Agreement of Harvey M. Schwartz, dated as of February 5, 2023 (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on May 4, 2023). | |
10.17+ | Employment Agreement of Lindsay LoBue, dated as of September 28, 2023 (incorporated by reference to Exhibit 10.21 to the Registrant’s Annual Report on Form 10-K filed with the SEC on February 27, 2025). | |
10.18+ | Operating Executive Consulting Agreement by and between Carlyle Investment Management L.L.C. and James H. Hance, dated as of November 1, 2012 (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on November 13, 2012). | |
10.19+ | The Carlyle Group Inc. Inducement Award – Form of Global Restricted Stock Unit Agreement (incorporated by reference to Exhibit 4.3 to the Registrant’s Registration Statement on Form S-8 filed with the SEC on February 13, 2023). | |
10.20+ | The Carlyle Group Inc. Inducement Award – Form of Performance-Based Restricted Stock Unit Agreement (incorporated by reference to Exhibit 4.4 to the Registrant’s Registration Statement on Form S-8 filed with the SEC on February 13, 2023). | |
10.21+ | Form of Global Restricted Stock Unit Agreement for Time-Based Awards (incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on May 4, 2023). | |
10.22+ | Form of Global Restricted Stock Unit Agreement for 2023 One-Time Time-Based Awards (incorporated by reference to Exhibit 10.5 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on May 4, 2023). | |
10.23+ | Form of Global Restricted Stock Unit Agreement for Time-Based Awards (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on May 9, 2025). | |
10.24+ | Form of Global Restricted Stock Unit Agreement for Bonus Deferral Awards (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on May 9, 2025). | |
10.25+ | Form of Global Performance-Based Restricted Stock Unit Agreement for Stock Price Appreciation PSU Award Program Awards (incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on May 9, 2025). | |
10.26*+ | Form of Global Performance-Based Restricted Stock Unit Agreement for Stock Price Appreciation PSU Award Program Awards (December 2025). | |
10.27+ | Form of Outside Director Deferral and Stock Election Form (incorporated by reference to Exhibit 10.34 to the Registrant’s Annual Report on Form 10-K filed with the SEC on February 27, 2025). | |
10.28+ | Form of Global Restricted Stock Unit Agreement for Time-Based Awards to Non-Employee Directors (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on August 8, 2025). | |
10.29+ | Form of Global Restricted Stock Unit Agreement for Vested Awards to Non-Employee Directors (incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on August 8, 2025). | |
10.30+ | Form of Restrictive Covenant Letter for Certain Executive Officers (incorporated by reference to Exhibit 10.32 to the Registrant’s Annual Report on Form 10-K filed with the SEC on February 22, 2024). | |
10.31 | Aircraft Lease Agreement, dated as of April 21, 2025, by and between Falstaff Partners LLC and Carlyle Investment Management L.L.C. (incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on August 8, 2025). | |
10.32 | Flight Support Services Agreement, dated as of April 18, 2025, by and between Jet Aviation Flights Services, Inc. and Carlyle Investment Management L.L.C. (incorporated by reference to Exhibit 10.5 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on August 8, 2025). | |
19.1* | The Carlyle Group Inc. Insider Trading Policy. | |
21.1* | Subsidiaries of the Registrant. | |
22* | Senior and Subordinated Notes, Issuers, and Guarantors. | |
23.1* | Consent of Ernst & Young LLP. | |
31.1* | Certification of the Chief Executive Officer pursuant to Rule 13a – 14(a). | |
31.2* | Certification of the Chief Financial Officer pursuant to Rule 13a – 14(a). | |
32.1** | Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
32.2** | Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
97 | The Carlyle Group Inc. Dodd-Frank Incentive Compensation Clawback Policy (incorporated by reference to Exhibit 97 to the Registrant’s Annual Report on Form 10-K filed with the SEC on February 22, 2024). | |
101.INS | Inline XBRL Instance Document - the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |
101.SCH | Inline XBRL Taxonomy Extension Schema Document. | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |
101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document. | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |
104 | The cover page from The Carlyle Group Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, formatted in Inline XBRL (included within the Exhibit 101 attachments). | |
The Carlyle Group Inc. | ||
By: | /s/ Justin V. Plouffe | |
Name: Justin V. Plouffe | ||
Title: Chief Financial Officer | ||
Signature | Title | |
/s/ Harvey M. Schwartz Harvey M. Schwartz | Chief Executive Officer and Director (principal executive officer) | |
/s/ Justin V. Plouffe Justin V. Plouffe | Chief Financial Officer (principal financial officer) | |
/s/ William E. Conway, Jr William E. Conway, Jr. | Co-Founder, Co-Chairman, and Director | |
/s/ David M. Rubenstein David M. Rubenstein | Co-Founder, Co-Chairman, and Director | |
/s/ Daniel A. D’Aniello Daniel A. D’Aniello | Co-Founder, Chairman Emeritus, and Director | |
/s/ Afsaneh M. Beschloss Afsaneh M. Beschloss | Director | |
/s/ Sharda Cherwoo Sharda Cherwoo | Director | |
/s/ Linda H. Filler Linda H. Filler | Director | |
/s/ Lawton W. Fitt Lawton W. Fitt | Director | |
/s/ James H. Hance, Jr. James H. Hance, Jr. | Director | |
/s/ Mark S. Ordan Mark S. Ordan | Director | |
/s/ Derica W. Rice Derica W. Rice | Director | |
/s/ William J. Shaw William J. Shaw | Director | |
/s/ Anthony Welters Anthony Welters | Director | |
/s/ Charles E. Andrews, Jr. Charles E. Andrews, Jr. | Chief Accounting Officer (principal accounting officer) | |